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ABSTRACT
This report summarizes the major activities and accomplishments of the Idaho National
Engineering and Environmental Laboratory (INEEL) Advanced Radiotherapy Research Program 
for calendar year 2001.  Applications of supportive research and development, as well as 
technology deployment in the fields of chemistry, radiation physics and dosimetry, and neutron 
source design and demonstration are described.  Contributions in the field of chemistry include
analysis of biological samples and continued effort focused on development of a blood-boron 
analyzer based on infrared spectrometry.  Contributions in the fields of physics and biophysics 
include development of advanced patient treatment planning software, feasibility studies of 
accelerator neutron source technology for Neutron Capture Therapy (NCT), and completion of 
major modifications to the research reactor at Washington State University to produce an 
epithermal-neutron beam for NCT research applications. 
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INEEL ADVANCED RADIOTHEAPY RESEARCH PROGRAM 
ANNUAL REPORT 2001
INTRODUCTION AND EXECUTIVE SUMMARY
The Idaho National Engineering and Environmental Laboratory (INEEL) Advanced
Radiotherapy Research Program completed its 15th year under the sponsorship of the U.S. 
Department of Energy (DOE), Office of Science (SC).  The program underwent a major external 
peer review during CY 2001.  As a result of this review, many ongoing activities were continued, 
a few others were reprioritized, and a new activity focused on collaboration with Lawrence
Livermore National Laboratory (LLNL), in the field of advanced treatment planning software 
development, was initiated during the fourth quarter.  This report includes detailed articles 
describing major INEEL activities and accomplishments during the year. 
A primary program goal has been, and continues to be, participation in the establishment of 
neutron capture therapy (NCT) as a clinically useful innovative radiotherapy in and of itself, or 
as an adjunct to fast-neutron therapy (FNT).  In addition, a new task involving the development
of advanced multi-modality computational dosimetry and treatment planning software with an 
initial emphasis on molecular targeted radionuclide applications was introduced during the year. 
The various program goals are accomplished through applications of supportive research and 
development and technology deployment in the fields of chemistry, radiation physics and 
dosimetry, and neutron source design and demonstration.  Many activities have been performed
in close collaboration with other DOE national laboratories and major universities.  Where a 
benefit to the U.S. NCT effort is realized, the INEEL also maintains formal cooperative 
arrangements with certain foreign collaborators, specifically in The Netherlands, Finland, 
Sweden, and Argentina. Finally, in light of the stated goals of DOE for technology transfer and 
commercialization, some aspects of the Program are operated in partnership with private U.S. 
industry through a Cooperative Research and Development Agreement (CRADA), as well as 
through several technology licensing agreements.  These arrangements have resulted in 
substantial leveraging of DOE-SC funding, especially in the important area of boron agent 
development.
The historical INEEL role as a center for quantitative boron analysis and radiation treatment
planning software development and deployment continued during 2001.  Biological samples and 
boron agent samples submitted to the INEEL by DOE-supported NCT research organizations
were analyzed for boron content in accordance with well-established standards, and the results
were reported back to the submitting organizations.  For the first three quarters of the year, work
continued on a real-time infrared blood-boron analyzer that will be able to sample the boron
content of a patient’s blood by infrared absorption spectrum techniques, since the absorption 
spectrum contains a feature common to all boron hydride compounds.  The internationally 
recognized INEEL SERA (Simulation Environment for Radiotherapy Applications) 
computational dosimetry and treatment planning software system continued to be supported 
during the year.  The initial release of SERA occurred in 1998, considerable refinement and 
additional feature development took place in 1999 and 2000, and the distribution version was 
stabilized in 2001.  NCT and FNT research centers worldwide serve as benchmarking and testing 
institutions for SERA, providing extremely valuable feedback and suggestions for improvement.
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With the completion of SERA, work has now begun on the new multimodality radiotherapy
treatment planning system, in collaboration with LLNL.  This effort will take advantage of the 
many benefits of using the Java programming language to create a “next-generation” system for
a wide variety of research applications. 
With the completion of the DOE-sponsored epithermal-neutron boron NCT (BNCT) clinical 
trials at Brookhaven National Laboratory (BNL), INEEL attention has shifted toward the 
continued development of new neutron source technologies useful for NCT and NCT-augmented
FNT, and toward additional basic research focused on the clinical introduction of improved
boron agents.  This has been done in connection with a longstanding relationship established 
with a CRADA partner, Neutron Therapies, Limited Liability Company (NTL), as well as under
separate collaborations with the University of Washington (UW) fast-neutron radiotherapy 
program, and with DOE-sponsored radiobiological research efforts conducted by the Washington 
State University (WSU) School of Veterinary Medicine.  Human biodistribution studies of one 
alternate boron agent continued through most of 2001 at UW under a Food and Drug 
Administration (FDA) approved protocol, with in-kind technical support from the INEEL.  These 
studies are in preparation for the possible future initiation of separately funded human trials of 
BNCT-enhanced FNT for certain lung tumors and high-grade brain tumors using the UW clinical
fast-neutron facility.  In addition, some small-animal radiobiology studies were conducted to 
provide an initial assessment of a new fast-neutron beam configuration at UW that was jointly
developed by INEEL and UW to improve the performance of the UW facility for NCT-
augmented FNT applications.  Furthermore, construction of a new epithermal neutron beam
facility for preclinical research at WSU was completed during the year in a collaborative effort 
of INEEL and WSU, with a significant funding component from internal WSU sources.
Finally, in addition to the baseline NCT activities supported directly at the INEEL by DOE-SC,
further supportive, but separate, collaborative BNCT-related university research is sponsored by 
the INEEL Laboratory Directed Research and Development (LDRD) Program.  Two 
INEEL/university NCT projects were completed during the year under this type of sponsorship. 
These were: 1) development by INEEL and Idaho State University of a concept for an electron
accelerator based epithermal-neutron source for BNCT; and, 2) investigation, by the University
of Tennessee, of the application of Positron Emission Tomography (PET) to the quantitative
imaging of boron agents in vivo, with incorporation of the resulting information into the
treatment planning process via the SERA system.  The first of these projects is documented in 
this report, while the second is documented separatelya.
_____________
a M..K. Kahn, L.F. Miller, G.W. Kabalka, T.F. Nichols, “Improving Existing BNCT Dosimetry by use of Registered
   PET and MRI Images”, Proceedings of the ANS Radiation Protection and Shielding Division 12th Biennial
   Topical Meeting, April 14-18, 2002, American Nuclear Society, Chicago Illinois.
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ANALYTICAL CHEMISTRY
W. F. Bauer and B. M. White 
Idaho National Engineering and Environmental Laboratory, Idaho Falls, ID 
INTRODUCTION
There were two basic analytical chemistry related functions during 2001.  The first of these 
functions was simply the determination of boron in a variety of biologically related samples
using inductively coupled plasma atomic emission spectroscopy (ICP-AES).  The second 
function was the continuation the task examine the feasibility of using some novel infrared 
devices to create a device to measure blood boron as boron hydrides in vivo, and is described in 
the next article, Application of Infrared Spectroscopy For The Determination of Boron in 
Biological Fluids.
DETERMINATION OF BORON IN BIOLOGICAL SAMPLES 
During 2001, 675 new samples were received for analysis.  With samples from FY 2000 and the 
additional QA samples, the total samples analyzed came to 1,195.  Of the samples received, 648 
were from dogs and/or rodents from the Boron Neutron Capture Therapy and related programs in 
Dr. P. Gavin’s group at Washington State University (WSU), 3 were of stock solutions to be sent 
to WSU and assorted other preparations from Dr. F. Hawthorne’s group at University of 
California, Los Angeles (UCLA), 16 were from the trials being done in conjunction with 
Neutron Therapies, Limited (NTL) at the University of Washington (UW), and 2 were from NTL 
(San Diego).  The anticipated level of samples from WSU never materialized in 2001 for various
reasons.  As the neutron beam comes on line, the anticipated number of samples from WSU will 
increase dramatically.  During 2002, samples are expected from UCLA, WSU, UW, Southwest 
Texas State University, and from George Kabalka at the University of Tennessee.  Many of the
samples from WSU are actually in support of the researchers from the other institutions. 
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APPLICATION OF INFRARED SPECTROSCOPY FOR THE 
DETERMINATION OF BORON IN BIOLOGICAL FLUIDS 
W. F. Bauer1, A. Suazo2 and C. Rae1
1.  Idaho National Engineering and Environmental Laboratory, Idaho Falls, ID
2.  Manitou Springs High School, Manitou Springs, CO (Summer Research Assistant) 
INTRODUCTION
Infrared spectroscopy has been suggested as a potential tool for boron determinations in Boron 
Nuclear Capture Therapy (BNCT) related studies.  Many of the boron delivery agents being 
considered for BNCT are polyhedral borane derivatives1-5.  The B-H stretch for these compounds
generally occurs in the 2400-2650 cm-1 region, a spectral region with little interference.  Using 
this spectral region, detection limits as low as 2.5-5 µg B/g in blood plasma have  been 
reported1-4.  Infrared analysis for B is rapid and selective, however, as discussed previously6, it is
limited by the achievable detection limits.  The strong absorbance by water throughout most of 
the mid-infrared spectral region limits the pathlength that can be used in the sample cell to
something less than a few 10s of microns.  Liquid handling cells with such short pathlengths are 
hard to deal with, and difficulties in filling and cleaning the cells while achieving reproducible
pathlengths are commonplace.  Attenuated total reflectance (ATR) is one method that has been
used in infrared (IR) spectroscopy to overcome the issues associated with short, non-
reproducible pathlengths7.
In ATR, the infrared beam from the spectrometer is passed into an internal reflectance element
(IRE) at an angle.  Because of the differences in the refractive index of the IRE and the 
surrounding medium at the interface, the beam is reflected back into the crystal.  The resulting 
evanescent wave penetrates the region between the IRE and the sample to a depth of ~1-2 µm
per reflection.  Therefore, as long at the surface of the IRE is covered with the sample to a depth
of > 1-2 µm, the effective pathlength is always reproducible. 
The authors are attempting to use attenuated total reflectance and some novel new infrared 
sources to build a benchtop laboratory instrument whose sole purpose is to measure boron from
polyhedral borane compounds in biological samples.  The instrument to be developed will be 
portable and capable of analysis of liquids and, possibly, solid samples.  This year’s work
focused upon the application and potential limitations of the ATR technique using a simple cell 
design with Fourier Transform Infrared Spectroscopy (FTIRS), and characterizing different
infrared sources to be used in a simple filter photometer that would be designed to determine
boron in biological samples routinely. 
EXPERIMENTAL METHODS
Solutions of GB-10 were prepared by simple dilutions from 10,000 µg 10B/g as GB10 stock 
solutions (Neutron Therapies, Inc.).  Solutions of sodium mercaptoundecahydrodo-decaborate
(BSH), 10B enriched BSH, and Li2B12H12 were prepared by weighing the dry salt from an Idaho 
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National Engineering and Environmental Laboratory (INEEL) archive sample and diluting with 
deionized water (18 megaohm).  Standards were prepared at 5, 10, 20, 30, 40, 50, 100, 150, 200 
and 250 µg B/mL.  Concentrations of the stock solutions and some of the diluted samples were
confirmed by inductively coupled plasma-optical emission spectroscopy (ICP-OES)8.
The ATR cell used for the FTIR studies was the Foundation Series Multi-Reflection HATR 
accessory (Thermo Spectra-Tech, Shelton CT) with a ZnSe internal reflection crystal mounted in 
a trough plate for liquid samples.  A Wilmad (Buena, NJ) VariPath transmission cell with CaF2
windows was used for the transmission measurements.  Infrared spectra were acquired on a 
BioRad (Hercules, CA) FTS 60 or a Bruker Equinox 55 FTIR spectrometer.  Scans were 
acquired on the FTS 60 equipped with a wide-band mercury cadmium telluride (MCT) detector
at 4 cm-1 resolution, and were typically an average of 32 scans at a mirror velocity 10 kHz. 
Scans acquired on the Equinox 55 were also acquired at 4 cm-1 resolution with a MCT detector,
but consisted of an average of 128 scans with a mirror velocity of 20 kHz.  Three spectra were 
collected for each standard by running through the entire sequence of standards for each analyte
three separate times.  In this way, many of the factors that influence baselines, such as the
repeated handling and cleaning of the ATR cell and time, are included into the calibration curve.
Data processing, including peak integration, peak height determinations, and partial least squares 
(PLS) analyses was performed in Grams/AI (Thermo Galactic).  All determinations were made
after a 2-point background correction at 2607 and 2392 cm-1.  Integration and PLS analysis were 
performed from 2610-2390 cm-1.
Flow injection analysis (FIA) was carried out with an experimental apparatus as shown in Figure 
1.  This apparatus consisted of a PulseIR or ReflectIR (Boston Electronics Corporation) thermal
source (Figure 2) controlled with a pulse generator programmed via an RS232 connection with 
the control computer (PC).  Although the ReflectIR source is collimated to a large degree due to
the housing, additional BaF2 lenses were used to further focus and collimate the beam.  The 
beam then passed through a Micro Demountable Flow-Thru Cell (Spectra-Tech) with CaF2
windows, and was focused with a BaF2 lens through a bandpass filter onto a PbSe detector 
(Electro-Optical Systems, Inc.) thermoelectrically cooled to –30°C.  The carrier stream was 
simply deionized water pumped at 1 mL/min with a peristaltic pump.  The sample was loaded 
into a 100 µL sample loop and injected into the carrier stream for analysis.  Analog output from 
the PbSe detector was digitized with a PCI-MIO-16e multifunction card (Digital Instruments)
using the source pulse as a trigger for the data acquisition.  Source control and data collection 
operations were performed with LabView software on the control computer (PC). 
RESULTS AND DISCUSSION 
ATR-FTIR Spectroscopy
Previously, the ability of ATR-FTIRS to determine B with reasonable accuracy and precision 
was demonstrated6.  Detection limits determined from the standard deviation of the y-intercept 
were ~5 µg 10B/mL as GB10.  GB10 is only one of many compound types containing multiple
B-H bonds that are being considered for use in BNCT.  To optimally design a filter photometer
5
FFigure 1.  Simple schematic of infrared filter photometer for determination of boron in biological
fluids by flow injection analysis. 
Figure 2. ReflectIR pulsed thermal sources on left with CaF2 windows and a continuous
miniature IR source (LC-IR-12k) with elliptical reflector to help collimate the beam shown on 
right.
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for B analysis, it will be important to fully understand the spectral characteristics and behavior of 
other B compounds of interest in the 2400-2650 cm-1 spectral region.  The availability of a
variety of compounds is somewhat limited, however, at the INEEL, there are multiple 10BSH,
BSH and Li2B12H12 samples available.
The standards of BSH, 10BSH, Li2B12H12 and GB10 were run on the Bruker Equinox 55 FTIR 
using the ZnSe ATR cell.  A problem was encountered with the BSH standards as the BSH reacts 
with the surface of the ZnSe surface, presumably via exchange of a Se and the sulfhydryl group
of BSH.  Figures 3 and 4 demonstrate the kinetics of this reaction using a 5 µg B/mL BSH 
solution.  The apparent concentration of B rapidly increases over the first couple of minutes and 
then increases much more slowly.  The reaction does not appear to be complete by 17 minutes.
By this time, the peak has more than doubled.  The reaction does not appear to be due to any of 
the oxidation products of BSH9-11, as the same results were obtained with aged solutions and 
freshly prepared solutions.  This reaction could potentially be viewed as an advantage in that it 
concentrates the boron compound on the surface, allowing much lower detection limits.
Unfortunately, the reaction is relatively slow for analytical purposes.  The BSH is bound rather 
tightly to the surface of the ZnSe IRE and can only be removed by several minutes of exposure 
to a sodium hydroxide solution. 
To collect data for the calibration curves of BSH, scanning was initiated after a 10 second delay 
from the time the sample was put in the cell.  After data collection, the cell was cleaned by 
exposure to the sodium hydroxide solution. The cleaning was repeated until no BSH was
apparent in the spectrum of blank deionized (DI) water.  Even with this cleaning, the calibration 
curves were nonlinear at the lowest concentration levels as demonstrated in Figure 5.  Fitting to a 
quadratic equation was still not adequate to describe the curve.  The lower concentration range of 
the curve appears to be dominated by the kinetics of the BSH reaction with the ZnSe surface. 
The lower concentration measurements are also much more precise, possibly owing to the 
number of surface sites being reacted in the same period of time at the different concentration
levels.  Use of peak areas rather than the peak heights did not improve the precision.  In fact, the 
precision was somewhat worse, possibly indicating that some baseline abnormalities may play a 
role in the poor reproducibility.  This would not be unexpected, as peaks with such a small net 
absorbance may be easily influenced by any minor spectral variability.  The shape of the curve in
Figure 4 does not appear to conform to a simple rate law suggesting either more than one type of 
binding site on the ZnSe IRE or there may be consecutive reactions.  In either case, each site or
reaction has its own rate.  This added level of uncertainty could also contribute to the lower 
precision at the higher concentrations. 
Even without knowing the exact reaction dynamics of the BSH with the ZnSe IRE, a calibration 
can be obtained using the method of PLS12.  This multivariate approach to calibration utilizes the
entire spectral range rather than just the peak height or peak area to determine concentration. 
The PLS calibration accommodates shifting baselines and can accommodate some nonlinearities.
Figure 6 plots the predicted concentrations vs. the actual concentrations for the PLS calibration
of 10B as BSH using the same spectra as in Figure 5.  The six factors used to describe the data set 
with the PLS appears to adequately describe the nonlinearities shown in Figure 5, as well as to 
describe  the  variations in the baselines that  contribute  to the  imprecision.  Interestingly, at  40 
7
0.001
.002
.003
.004
Ab
so
rb
an
ce
 2600  2550  2500  2450  2400 
Wavenumber (cm-1)
T=0 min
T=17.2 min
5 µg B/mL as BSH
Figure 3.  Reaction of BSH with ZnSe is demonstrated with 5 µg 10B/mL as BSH. 
0.05
0.07
0.09
0.11
0.13
0 2 4 6 8 10 12 14 16 18
Time (min)
Pe
ak
 A
re
a 
(A
bs
)
Figure 4.  Summary of the data in Figure 1 showing the increase in peak area with
time of exposure for 5 µg 10B as BSH on a ZnSe ATR element (n = 32 scans). 
8
0.0000
0.0005
0.0010
0.0015
0.0020
0.0025
0.0030
0.0035
0.0040
0.0045
0.0050
0 50 100 150 200 250
µg 10B/mL as BSH
Pe
ak
 H
ei
gh
t (
Ab
s)
y=-8.7e-8·x2 + 3.6e-5·x + 2.8e-4
R2 = 0.94
Figure 5.  Boron concentration plotted vs. peak height for BSH determined by FTIR ATR
with a ZnSe crystal.  At the low concentration end, sorption of BSH to the ZnSe crystal
dominates.
-15
25
65
105
145
185
225
265
-15 35 85 135 185 235
Actual µg 10B/mL (10BSH)
Fo
un
d 
µg
 10
B/
m
L 
(1
0 B
SH
) PLS for 10B as 10BSH
BG Corrected
2610-2390 cm-1
Factors = 6
R2 = 0.9975
Figure 6.  Same data as in Figure 5 using PLS calibration model.
9
µg 10B/mL, the 10B concentration is underestimated and the error largest.  This appears to be 
where two portions of the curve shown in Figure 5 meet.  In any case, the R2 is 0.9975, and the 
estimated detection limit using three times the standard deviation of the y-intercept of the curve 
plotted in Figure 6 is 2.1 µg/mL.  Similar results were obtained with the natural abundance boron 
BSH.
The calibration curves for 10B as GB10 and B as Li2B12H12 are typified by the calibration curve
for Li2B12H12 using peak heights shown in Figure 7.  The R2 is greater than 0.98, and the 
detection limits determined at three times the standard deviation of the y-intercept typically
range from 7 to 8 µg B/mL when using peak heights.  Peak areas tended to be slightly worse 
with the detection limits ranging from 8-11 µg B/mL.  Again, because of the extremely low 
observed absorbance values, any variations in the spectral background can have a negative effect 
upon the results.  If the spectral shapes of these backgrounds can be modeled by a multivariate 
calibration method, then higher precision and lower detection limits can be achieved.  Figure 8 
shows the results of the PLS calibration using the same spectra as used for Figure 7.  The R2 is 
raised to > 0.99 and the detection limits are in the 2.5-3.2 µg B/g range. 
Because of the nature of absorbance spectroscopy, a calibration, once developed, should be
universal since the absorption coefficients at each wavelength are constants.  Figure 9 depicts the 
results for the determination of boron concentrations for a set of standards prepared with GB10 
in late 2001 using a PLS calibration made with a different set of standards prepared and analyzed 
in September, 2000 on a different FTIR instrument.  The calibration was developed using spectra 
collected with the ATR cell mounted in the FTS 65.  The spectra of the standards analyzed as 
unknowns were collected ~1 year later on the Equinox 55.  The correlation between the two sets 
of spectra is quite good as the R2 is greater than 0.99.  However, the slope and y-intercept
indicate that there is slight bias and offset.  The reason for the bias is unknown, but may be 
related to the different apodization functions used to process the interferograms13,14.  Although, 
due the naturally wide peaks of the analyte relative to the instrument resolution, any differences 
caused by the apodization functions will be at a minimum.  The FTS 65 and Equinox 55
interferograms were processed with Happ-Genzel and weak Norton-Beer apodization functions, 
respectively.  Calibration transfers are often adversely affected by some unknown instrument
function, however, the calibrations can easily be corrected with a normalization function 
determined from a set of standards, or by slightly more involved methods if necessary15.
Development of an Infrared Filter Photometer for B determinations 
Previous work with IR light emitting diodes (IRLEDs) indicated that there was some possibility 
that they may be suitable for use in a filter photometer dedicated to boron determination.
However, because of their low power output (2 mW) and the large degree of attenuation by the 
optical components and water, it was decided that they were not the most suitable technology for
this application at this time.  The output wavelengths of the IRLEDs were also optimized for
carbon dioxide and hydrocarbon determinations. Boron determinations were only possible by 
virtue of the wide bandpass of the IRLED that encompassed the B-H stretch in the tail.  The 
search for alternative small IR sources led to some very simple miniature thermal sources.  These
sources are relatively inexpensive at < $70, and come in pulsed and continuous output versions. 
The  main  advantage  that  the IRLED  has  over  the  pulsed  thermal  sources  is  that  it  can 
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be operated at rates as high as 1,000 Hz.  The PulseIR and ReflectIR sources can operate at a 
maximum pulse rate of only about 12 Hz.  The main advantage of the pulsed thermal sources
over the IRLEDs is that the output power can be as high at 1.75 W.  Even with the attenuation by 
the optical components and water, enough light reaches the detector with the pulsed thermal
sources to make them a much better alternative to the IRLEDs.  The miniature continuous output 
thermal sources can output up to 9 W, but a chopper is required to modulate the signal since 
most IR detectors operate in AC in order to handle the large DC backgrounds. 
This year the work centered primarily upon incorporating the ReflectIR source into the system 
and understanding the optimum conditions under which it can be operated.  The pulse is actually 
a two step square-wave consisting of a warm-up phase and a sustained phase.  Generally, for this
application, the best response was achieved with a warm-up phase of 12 ms at 2.8 A, a sustained 
phase of 3 ms at 0.8 A and a 18.8% duty cycle for a total of 80 ms/pulse.  These parameters tend 
to push the source to its limit and will ultimately shorten the lifetime of the source, however, 
they do provide sufficient detector response so that small changes may be noted. 
Initially, the ATR cell was being used, however, the noise level achievable did not seem to be 
accurate.  Much of the problem with the ATR cell may be related to the offsets noted in the FTIR 
spectra.  It had been noted on the FTIR that each time the ATR cell is removed to change 
samples and replaced onto its base, there was a baseline offset that varied by as much as ± 0.003 
absorbance units.  Offsets and drifting baselines are easily corrected when the whole spectrum is 
available.  However, with only the single bandpass filter and detector, offsets and drifting 
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baselines of this magnitude are a limiting factor, given the ~10 µm pathlength of the ATR cell 
and the minimal absorbance of the analyte.
With FIA, the baseline is continuously being monitored between injection samples, removing
some of the limitations associated with having only one filter and one detector.  Therefore, the
ATR cell was removed from the experimental setup and replaced with a flow cell equipped with 
CaF2 windows.  Because the absorbance of water is at a minimum near the B-H absorption band,
a reasonable signal at the detector was obtainable with the pathlength expanded to 100 µm. 
Figure 10 is an example of a FIA run using the apparatus shown in Figure 1 with the 100 µm 
pathlength cell.  The drifting baseline is readily apparent, but the injections of the samples are 
also easily noted.  The peak-to-peak noise is > 0.0005 absorbance units.  This noise-level is 
currently too high for use with the ATR cell, but may be approaching usefulness with the 100 
µm transmission cell, as the 10 µg B/mL injections are readily apparent.  The cause for the 
baseline jump near the end of the experiment is unknown, but suspected to be associated with 
some change in the laboratory environment.  Reduction in the noise level and stabilization of the
baseline is anticipated once the apparatus is fully enclosed in a housing and isolated from the 
variable laboratory environment.
CONCLUSIONS
The feasibility using ATR-FTIR for the determination of B with different boron compounds
containing multiple B-H bonds has been demonstrated.  With the multivariate processing of the
IR spectra in the region of the B-H stretch, detection limits < 5 µg B/g should be routinely 
achievable.  For monitoring blood-boron concentrations, this could be a relatively important
application because it eliminates problems associated with the use of short pathlength
transmission cells, eliminates the need for any sample preparation as is required for the standard
ICP techniques, and it can be performed using relatively low cost Fourier transform (FT) or 
dispersive IR instruments which have a much smaller footprint and essentially no facility 
requirements as the ICP instruments do.  It is conceivable that the ATR-IR instrument can be
mobile enough to be placed at the patient’s bedside while the B infusion and B elimination are 
being monitored.
An even more compact and low cost alternative to the ATR-IR technique would be a simple
filter photometer that is designed specifically to detect the B-H stretch.  The feasibility of this 
approach has been demonstrated using a low cost pulsed infrared source, a flow cell, an optical 
filter, and a PbSe detector.  Operated in the FIA mode, this simple apparatus is currently capable
of detecting B in liquids containing B compounds with B-H bonds at levels of ~10 µg B/mL or 
less.  With some minor improvements to control noise, the detection limits for this apparatus
may exceed those achieved by the ATR-FTIR as described above because the pathlength can be 
extended to 100 + µm.  Improvements include encasing the components for climate control, and 
better signal conditioning, either digitally or electronically. 
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INTRODUCTION
Attention1 has been focused upon the development of a convenient, local epithermal-neutron
beam facility at Washington State University (WSU) for collaborative Idaho National
Engineering and Environmental Laboratory (INEEL)/WSU BNCT preclinical research and 
boronated pharmaceutical screening in cell and animal models.  The design of the new facility,
which is installed in the thermal column region of the TRIGAa research reactor at WSU, was 
performed in a collaborative effort2,3 of WSU and INEEL scientists.  This article summarizes the 
physical construction and assembly of the beamline components.
FACILITY DESCRIPTION
The 1 MW reactor core is suspended from a movable bridge above the pool as shown in Figure 
1.  It can be positioned directly adjacent to a truncated aluminum cone that extends horizontally 
into the reactor pool from the tank wall on the upstream side of a large shield wall penetration. 
This cone and the adjacent volume were originally filled with graphite, comprising what was 
known as the ‘thermal column’.  A lead wall and water-filled shield were located downstream of 
the graphite portion of thermal column.  There was a large open floor area outside of this final 
shield, as shown in Figure 2.  Figure 3 shows a schematic diagram of the components of the
WSU epithermal-neutron beam facility that were installed in the original thermal column region 
of the reactor-shielding monolith.  In this design, the original graphite has been removed from 
this region and replaced with an epithermal-neutron filtering, moderating, and collimating
assembly, as shown.  Neutrons emanating from the core travel into the filtering and moderating
region.  The spectrum is tailored in this region such that most neutrons emerge with energies in
the epithermal energy range (0.5 eV – 10 keV).  Downstream of the filtering and moderating
region is a cadmium thermal neutron absorber, a bismuth and lead gamma shield, and a conical 
neutron collimator composed of bismuth surrounded by borated polyethylene.  A final layer of 
lithiated polyethylene covers the lead face.  Provision is made for several different exit port
aperture sizes, as shown in Figure 3.  A heavily shielded concrete beam stop and treatment room 
has been constructed just outside of the thermal column opening in the reactor shield wall, as
shown in Figure 4. 
a  TRIGA is a trademark of General Atomics of San Diego, CA.
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Figure 1.  Elevation plan of the WSU TRIGA reactor facility.
Figure 2.  Final thermal column shield (water-filled door) and adjacent floor area at the WSU
TRIGA facility prior to modifications.
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Figure 3.  WSU column assembly, with epithermal-neutron filter in place.
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A key distinguishing feature of the WSU facility is the incorporation of a new, high-efficiency, 
neutron moderating and filtering material, FLUENTALb, into the design.  FLUENTAL,
developed by the Technical Research Centre of Finland4, is manufactured by hot isostatic 
pressing of a powered mixture of 69% (by weight) aluminum fluoride, 30% aluminum, and 1% 
lithium fluoride.  A block of this material, having a thickness in the beam propagation direction
of 0.64 m and transverse dimensions of approximately 0.6 m, is surrounded by aluminum oxide 
to produce the neutron filtering and moderating region, as shown in Figure 3.  MCNP5 and
DORT6 radiation transport design calculations for the coupled core and filter-collimator
assembly indicate that an epithermal-neutron flux of approximately 109 n/cm2-s at a reactor
power of 1 MW will be produced at the exit port of the collimator (with the reactor core 
optimally loaded).  The background neutron KERMA factor (a measure of the fast-neutron 
contamination) for the beam is calculated to be approximately 3.0 x 10-11 cGy/n-cm2.  The
computational methods used for this design were previously validated against INEEL
measurements performed for a similar neutron beam facility that is in operation at the FiR 1 
TRIGA research reactor in Finland7.
An additional key feature of the WSU beam facility design is the provision for adjustable filter-
moderator thickness (in 4 cm steps) to systematically explore the radiobiological consequences
of increasing the fast-neutron contamination above the nominal value associated with the 
baseline system described above.  The components shown in Figure 3 are designed for relative 
ease of disassembly and re-assembly, compared to other reactor-based epithermal-neutron
facilities that are currently in operation.  Thus, it will be possible to have a number of different
filter/moderator arrangements over the life of the facility.
CONSTRUCTION
Figure 5 is a view into the original thermal column prior to assembly of the filter.  The thermal
column is a steel box lined with boral [aluminum-boron carbide-aluminum sandwich 0.635 cm
(0.25 inches) thick].  The top and side boral sheets are held in place by the other filter 
components, i.e., they are not attached to the walls, so that there are no penetrations into the steel 
box liner. 
Thermocouples and Nitrogen Vent Line 
Prior to installation of the filter-moderator components, thermocouples were placed at selected
locations on the primary gamma shielding at the far end of the thermal column cone housing, as 
shown in Figure 6.  This shielding is composed of lead, and is subject to heavy gamma heating 
from the adjacent reactor core.  Five thermocouple leads were attached to the lead via screws or
inserted into spaces in the lead; the sixth lead is attached to the center of the boral sheet facing
the cone.  The Type K thermocouples were procured from Omega Engineering (Catalog number
WTK-8-S 240-TT), and connected to a thermocouple readout meter outside the beam-stop room 
(Omega Model DP462).  The leads from the thermocouples were brought out the bottom center 
of the assembly through slots cut into the first five rows of alumina bricks, and then routed to the 
right side of the thermal column, taking advantage of the first offset in the wall of the thermal
column.  These  cables  were then run along  the bottom  right  side of the thermal column, out to 
b  FLUENTAL is a trademark of The Technical Research Centre of Finland.
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Figure 5.  View into the thermal column prior to assembly.  Note the sheets of boral on the 
sidewalls, several of the aluminum oxide bricks on the floor near the cone, and the offsets in the 
walls.
Figure 6.  Thermocouple installation in the upstream gamma-shielding region of the WSU
thermal column cone showing the leads brought out the center of the alumina blocks. 
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the cable penetration port in the beam room.  Also included with the thermocouple leads was a 
0.635 cm (0.25-inch) diameter nylon tube that vents into the bottom of the cone area.  This vent 
was provided to supply a nitrogen-purge in the cone area to reduce air activation, and is typically 
connected to a nitrogen supply outside the beam-stop room.
Aluminum Oxide and FLUENTAL Assembly 
The primary filter moderator-filter assembly was then built up from blocks of aluminum oxide 
and FLUENTAL, as shown in Figure 7 for the partially completed assembly, and in Figure 8 for 
the fully completed assembly.  A sheet of boral prevents the blocks from falling into the cone 
area, and reduces the thermal neutron flux impinging on the upstream side of the filter-moderator
region.
The FLUENTAL material consists of 17 blocks of nominal dimensions 63.5 x 22 x 8 cm, 8 
blocks of 63.5 x 11 x 8 cm, and 6 blocks of 63.5 x 22 x 4 cm.  This allows stacking the blocks in 
a cube arrangement of 8 rows measuring 63.5 x 64 x 66 cm (25 x 25.2 x 26 in) when completed.
The 4 cm thick blocks make it possible to shorten the filter in 4 cm increments if desired.  The 
alumina blocks were produced in 8 x 8 x 16 cm size by Coors Ceramics (Golden, CO.) to mate
with the FLUENTAL.  These blocks were stacked with an offset in both directions to minimize
neutron-streaming paths.  The vertical offset was established by cutting (using a diamond tile 
saw) 1 cm off the bottom row of alumina blocks in rows 2 and 4.  Rows 6 and 8 were stacked on 
the floor (utilizes a step in the thermal column construction), and row 7 was elevated by using 
the 1 cm pieces left over from rows 2 and 4.  The horizontal offset was established by offsetting
the FLUENTAL blocks 1.3 cm (1/2 in) left-to-right between rows.  The alumina blocks at the
sides and top edges of the thermal column were cut to fit.
Figure 7.  Partially completed WSU filter-moderator assembly, showing the FLUENTAL and 
alumina blocks, and the boral backing sheet.  Note the offsets in both directions. 
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Figure 8.  Completed WSU filter-moderator assembly.
Cadmium Assembly 
Cadmium sheets, 0.12 mm (.030 in) thick, 30.5 x 183 cm (12 x 72 in), were ‘hung’ over the end 
of the above assembly by tucking the end of the cadmium sheet into the small space between the 
ceiling and the top alumina blocks.  Figure 9 is a photo of the cadmium sheets in place. 
Figure 9.  Cadmium thermal neutron shield. 
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Gamma Shield 
The next assembly installed was the gamma shield. This consisted of 10 cm (4 in) of lead bricks
covering the outside area of the alumina blocks, and 10 cm (4 in) of bismuth covering the 
FLUENTAL region.  The lead bricks are stacked on edge, with an overlapping design to prevent 
streaming.  Four interlocking bismuth shield blocks, designed to mate with the lead bricks, were 
cast at the INEEL.  A special lifting jig was built to lift the blocks into place [they weigh about 
55 kg (340 lb) ea].  An automotive engine hoist was used to supply the lifting force.  Figure 10 
shows the device in operation. 
Figure 10.  Bismuth gamma shield block hanging on the lifting jig. Note the offsets built into the
bismuth block to mate with the lead bricks. 
Figure 11 shows the detail of the offsets built into the bismuth blocks; how they mate with each 
other and with the lead bricks.  Figure 12 shows the completed lead wall gamma shield with the 
bismuth blocks covering the area in front of the FLUENTAL blocks. 
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Figure 11.  Detail of the bismuth gamma shield blocks, 5cm (2 in) offsets at the top/bottom and 
sides.
Figure 12.  Completed gamma shield assembly.
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Collimator Design 
The design of the cone-shaped bismuth collimator was based on a tradeoff of cone height to 
maximize the collimation versus the loss of intensity of the neutrons due to increased distance 
from the reactor core.  The final design selected was a truncated right circular cone with a base
opening diameter of 91.4 cm (36 in), a height of 38.1 cm (15 in), and a wall thickness of 3 cm
(1.2 in).  The angle of the cone is 45 degrees, giving an opening of 15.24 cm (6 in).  The final 5 
cm (2 in) of the cone is fitted with a collar, designed so that various shaped apertures can be 
fabricated from lithiated polyethylene and inserted in a flanged opening. 
The actual construction of the collimator bismuth sections presented a challenge due to the final
weight [> 270 kg (600 pounds)] of the finished bismuth cone.  The design decision was to make
the collimator out of 16 sections, much like barrel staves.  A mold was constructed of aluminum,
and the sections were formed from molten bismuth.  The inside surface of the individual section 
was the free surface of the mold, which was machined off (bismuth expands when cooled from a 
liquid) to provide a smooth surface.  Each of the 16 pieces weighs about 18 kg (40 pounds).
Figure 13 is a photograph of a finished section. 
Figure 13.  Bismuth collimator section. 
The bismuth cone is supported by borated polyethylene (Reactor Experiments, 5% Borated 
Polyethylene, Catalog Number 201) for the first 28 cm (11 in), and two rows [10.16 cm (4 in)] of 
lead bricks.  The last five cm (2 in) of the bismuth staves are fitted with a bismuth collar, as 
shown in Figure 15, designed to provide a transition from the cone shape to mate with the lead 
bricks while providing shielding for the capture gammas generated from the boron in the
polyethylene.
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Figure 14 is a drawing of the completed collimator, showing the interlocking features of the 
staves.
Figure 14.  Bismuth collimator.
The collar was formed in a mold also, in two pieces due to the final weight (~45 kg, 100 lbs 
each).  This bismuth collar will accommodate lithiated polyethylene final neutron beam 
delimiters.
Figure 15.  Collimator collar, a rear and front view.  Staves fit in the tapered area, and the 
delimiter fits into the square flange area. 
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Collimator Assembly 
The collimator assembly was put together in two halves, lower and upper.  The poly sheets, 
which are numbered from 1 to 11 and have the corresponding cone shape cut in them, were
bolted together with 11.4 cm (4.5 in) long, 1.6 cm (5/8 in) nylon bolts.  The boltholes are
designed to have a captive nut (Figure 16) on the side facing the reactor, and the bolt with
fiberglass washer can be threaded through the holes and tightened with a socket wrench.  The 
purpose of the bolts is too prevent the poly sheets from separating and sliding on each other, so 
the bolts are used in sheer rather than in tension.  There are three sets of seven bolts required to 
assemble each the bottom and top halves, with the holes offset to prevent streaming paths.  The 
final bolt heads are not recessed into the poly, and required the adjacent lead bricks to have a 
relief cutout to accommodate the bolt head. 
Figure 16.  Captive nut inserted into polyethylene. 
With the lower half of the poly in position with accompanying sidepieces (Figure 17), the front 
lead bricks were assembled up to the level of the collimator collar.  The lower half of the collar
was placed on the lead (Figure 18), and then the bismuth staves put into position.  Each half of 
the collar weighs approximately 45 kg (100 lb), and each stave weighs approximately 18 kg (40 
lb).  The collimator was assembled by starting with the center bottom stave and working up
either side to the halfway point.  The bottom seven staves are pinned to the collar with 0.635 cm 
(0.25 in) diameter aluminum rod (6061) (Figure 19).  At this point, a carbon fiber ring 
(fabricated by Spencer Composites Corp., Sacramento, CA) was put in place at the rear of the 
assembly, and a lexan ring inserted at the front of the assembly (Figure 20).  These rings provide
support for the top half of the collimator staves.  With the staves all in position, (Figure 21) the 
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top half of the poly was assembled, bolted together as described for the bottom section.  With the
top half of the poly in place, the upper bismuth collar was positioned (Figure 22), and lead bricks
continued up to the level of the top of the collar.  The top of the collar and accompanying lead 
bricks are used to support the final large bismuth lintel piece (Figure 23).  This lintel piece
weighs about 155 kg (340 lb), and required the engine hoist and lifting jig to lift it into place. 
With the lintel positioned, the remainder of the lead bricks were added to complete the lead wall.
The lead wall is covered with lithiated polyethylene, held in place with nylon bolts, as shown in 
Figure 24.  Figure 25 is a cut-away cross section of the collimator section, bismuth shield, and 
the filter (Al2O3 and AlF3).
Figure 17.  Lower half of the polyethylene in position, lead bricks to the bottom half-collar. 
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Figure 18.  Lower half of the collar in position on the lead wall. 
Figure 19.  First stave in position.  Note the partially inserted aluminum rod used to pin the stave 
to the collar.  The bottom seven staves were pinned to the collar.
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Figure 20.  Carbon fiber and lexan rings in place. 
Figure 21.  Top half of collimator staves in place. 
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Figure 22.  Upper half of collar in place. 
Figure 23.  Lintel piece in place above the collar, showing the lead bricks carrying the load. 
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Figure 24.  Outer face of the filter-moderator region showing lithiated polyethylene in place.
The four inch collimator is in position. 
DISASSEMBLY
Disassembly of the collimator/filter can be accomplished in reverse of the assembly.  Careful 
note should be taken of the various components (lead bricks, aluminum oxide blocks) that have 
been ‘cut-to-fit’.  There will be approximately 6,273 kg (13,800 lb) of lead (500 bricks), 5,227 
kg (11,500 lb) of aluminum oxide (1,300 blocks), 1,045 kg (2,300 lb) bismuth and 804.5 kg 
(1,770 lb) of FLUENTALa to deal with. 
a  The FLUENTAL blocks will contain small, but noneligible, quantities of elemental tritium, built up during
irradiation, and they should be handled accordingly.
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Figure 25.  Cut-away cross section of the collimator section, bismuth shield, and the filter. 
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INTRODUCTION
Veterinary radiation oncology researchers at the Washington State University (WSU) School of 
Veterinary Medicine have made major contributions to the understanding of the in-vivo
radiobiology of Boron Neutron Capture Therapy (BNCT) over the years.  For example, the large-
animal model studies of normal brain tissue tolerance in BNCT conducted by this group1
provided a key component of the radiobiological basis for the resumption of human BNCT trials 
in the U.S. in 1994.  Those studies used the epithermal-neutron beams available at Brookhaven 
National Laboratory and at the Petten facility, in The Netherlands, with technical support from 
the Idaho National Engineering and Environmental Laboratory (INEEL) in several areas of 
physics, biophysics, and analytical chemistry.  More recently, attention has been focused upon 
the construction of a more convenient and cost-effective local epithermal-neutron beam facility
at WSU for collaborative INEEL/WSU BNCT preclinical research and boronated pharmaceutical
screening in cell and animal models.  The design2,3 and construction4,5 of the new facility, which
has now been installed in the thermal column region of the TRIGAa research reactor at WSU,
was performed in a collaborative effort of WSU and the INEEL.  This article summarizes the 
results of some initial neutronic performance measurements for the WSU beam that were 
completed during CY 2001.
FACILITY DESCRIPTION
The 1 MW WSU reactor core is suspended from a movable bridge above the pool as shown in
Figure 1.  It can be positioned directly adjacent to a truncated aluminum cone that extends
horizontally into the reactor pool from the tank wall on the upstream side of the filtering and 
moderating assembly.  This cone and the adjacent thermal column area were originally filled
with graphite, comprising the thermal neutron column (or thermal column) for the WSU Nuclear 
Radiation Center.  A water-filled shield was located on the downstream of the graphite thermal
column.  There was a large open floor area outside of this final shield.
a TRIGA is a trademark of General Atomics of San Diego, CA.
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Figure 1.  Elevation plan of the WSU TRIGA reactor facility.
Figure 2 shows a schematic diagram of the WSU epithermal-neutron beam facility.  The new 
epithermal-neutron beam extraction components are located in the thermal-column region of the 
reactor-shielding monolith.  In this design, the original graphite has been removed from this
region and replaced with a new epithermal-neutron filtering, moderating, and collimating
assembly as shown.  Neutrons emanating from the core travel into the filtering and moderating
region.  The spectrum is tailored in this region such that most neutrons emerge with energies in
the epithermal energy range (0.5 eV – 10 keV).  Downstream of the filtering and moderating
region is a bismuth and lead gamma shield, followed by a conical neutron collimator composed
of bismuth surrounded by lithiated polyethylene.  Provision is made for several different exit port
aperture sizes as shown.  A heavily shielded concrete beam stop and treatment room has been 
constructed just outside of the thermal column opening in the reactor shield wall as shown in 
Figure 3. 
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Figure 2.  WSU column assembly, with epithermal neutron filter in place.
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Figure 3.  Approximate WSU beam stop and treatment room arrangement.
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A key distinguishing feature of the WSU facility is the incorporation of a new, high-efficiency, 
neutron moderating and filtering material (FLUENTAL)b developed by the Technical Research 
Centre of Finland6 into the design.  FLUENTAL is manufactured by hot isostatic pressing of a
mixture of 69% (by weight) aluminum fluoride, 30% aluminum, and 1% lithium fluoride.  A 
block of this material having a thickness in the beam propagation direction of 0.64 m and 
transverse dimensions of approximately 0.6 m is surrounded by aluminum oxide to produce the 
neutron filtering and moderating region as shown in Figure 2.  MCNP7 and DORT8 radiation
transport design calculations for the coupled core and filter-collimator assembly indicate that a 
free-beam epithermal neutron flux of approximately 109 n/cm2-s at a reactor power of 1 MW will 
be produced at the exit port of the collimator (with the reactor core optimally loaded).  The 
background neutron KERMA rate per unit useful epithermal neutron flux (a measure of the fast-
neutron contamination) for the beam is calculated to be approximately 3.0 x 10-11 cGy/n-cm2.
The computational methods used for this design were previously validated against INEEL 
measurements performed for a similar neutron beam facility that is already in operation at the
FiR1 TRIGA research reactor in Finland9.
An additional key feature of the WSU beam facility design is the provision for adjustable filter-
moderator thickness to systematically explore the radiobiological consequences of increasing the 
fast-neutron contamination (harden the beam) above the nominal value associated with the 
baseline system described above.  This is an important clinical issue for BNCT.  Thinner 
filter/moderator arrangements will produce epithermal beams having correspondingly harder 
spectra and greater levels of fast-neutron contamination.  The components shown in Figure 2 are 
designed for relative ease of disassembly and re-assembly compared to other reactor-based
epithermal-neutron facilities that are currently in operation.  Thus, it will be possible to have a 
number of different filter/moderator arrangements over the life of the facility.
Construction of the new WSU beam facility was initiated in 1999, and largely completed during 
2001 with the installation of the final bismuth collimator and surrounding shielding as shown in
Figure 4. 
b  FLUENTAL is a trademark of the Technical Research Center of Finland.
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                          (a)                                                                                (c) 
                              (b)                (d) 
Figure 4.  Final beam collimator installation at WSU showing the partially installed collimator
(a), the fully installed collimator with square exit port collar and lower borated polyethylene 
shielding (b), the upper borated polyethylene shielding (c), and the final lead shielding (d). 
The collimator, assembled from 16 identical bismuth “barrel-stave like ” castings, is a truncated 
right circular cone with a base opening diameter of 91.4 cm (36 in), a height of 38.1 cm (15 in), 
and a wall thickness of 3 cm (1.2 in).  The angle of the cone is 45 degrees.  It is supported by 
borated polyethylene and two rows of lead bricks as shown in Figure 4b.  The downstream end 
of the collimator is fitted with a bismuth collar designed to provide a transition from circular
shape of the cone to the square shape required to match with the lead shielding bricks comprising
the final shield wall.  The collar will accommodate borated or lithiated polyethylene inserts
having various beam port aperture sizes and field shaping configurations as shown in Figure 2. 
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INITIAL NEUTRON SPECTRUM MEASUREMENTS
After installation of the collimator assembly, some initial measurements were made to 
characterize the neutron spectrum in an imaginary transverse “source plane” passing through the 
base of the square flange on the downstream side of the bismuth collar.  The source plane is a 
mathematical construct used for specifying the neutron source boundary conditions for the 
various dosimetry and treatment planning computations that will be required to support each
experimental irradiation at WSU.  By definition, the physical beamline components upstream of 
the source plane do not change from one irradiation to the next. Components downstream of this 
plane, such as the previously mentioned lithiated polyethylene field shaping plates, can change 
for each irradiation and are, therefore, explicitly modeled in dosimetry and treatment planning
computations.  Time-consuming beam modeling computations are thus only done once for each 
beamline configuration upstream of the source plane, and the results are coupled to the patient 
dosimetry computations for each irradiation via a computed boundary condition specified for the 
source plane and validated by appropriate measurements.
The measurements reported here were based on a simplified version of the activation foil
protocol that was used for earlier INEEL measurements at the FiR 1 epithermal-neutron facility 
operated by the Technical Research Centre of Finland9.  That protocol, in turn, was based on 
neutron activation analysis techniques10 that have been adapted for BNCT applications by the 
INEEL through extensive experience with several other epithermal-neutron facilities in the U.S. 
and in Europe.  Neutronically thick circular activation foils of various types were used for the
measurements.  The foil specifications and corresponding neutron activation interactions of 
interest are listed in Table 1.  A very limited set of foils was used for these initial measurements
compared to the FiR 1 protocol.
Table 1.  Activation interactions and foils used for the INEEL/WSU preliminary epithermal-
neutron beam measurements.
Neutron
Interaction
Energy Range of 
Primary Response 
Activation Gamma Energy of 
Interest (keV)
115In (n, Ȗ) 1 eV Resonance 1293,1097, and 416 
197Au (n, Ȗ) 5 eV Resonance 411
63Cu (n, Ȗ) 1 keV Resonance 511 (Positron) 
115In (n,n') 430 keV Threshold 336
Positioning of Foils in the Beam 
Standard 12.7-mm (0.5 in) diameter Au, Cu, and In foils were used with a lexan foil positioning
plate shown in Figure 5a.  A cadmium cover was placed around one foil of each type to suppress 
the thermal-neutron response.  Thus, each foil responds largely to neutrons having energies at or 
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near the energy of the respective primary resonance of the foil material, as shown in the first 
three lines of Table 1.  The three covered foils were placed in three of the outer foil positioning
plate positions.  An uncovered gold foil was placed in a fourth outer position of the foil plate to 
measure the thermal flux.  The foils had nominal thicknesses in the range of 0.0254 mm (0.001 
in) to 0.127 mm (0.005 in), depending on the material type.
                                    (a)                                                                            (b) 
Figure 5.  Activation foil plate (a) positioned in the WSU epithermal neutron beam source plane
(b).
An additional foil package was used to provide spectral information in the high-energy range.  A
heavy (~5 g) 25.4-mm (1 in) diameter indium foil was placed in a small hollow boron sphere 
shown (disassembled) in Figure 6.  The composition of the sphere is approximately 93% 10B and 
7% 11B by weight, with a total boron density of 2.6 g/cm3.  This arrangement provides essentially 
total suppression of thermal and epithermal flux within the inner cavity of the boron sphere.
Thus, an artificial threshold above the resonance energy range is imposed on the neutron capture 
reactions in the foil within the sphere.  Since the activation gamma emissions that arise from 
neutron capture in indium are thereby suppressed, the relatively weak 336 keV gamma line from 
inelastic scatter in indium, which is of crucial interest in these measurements, is much more
prominent in the spectrum of the activated indium foil.  The activated indium foil is also much
easier to handle when the boron sphere is used in this manner, since the induced activity is
significantly lower than it would be without the sphere.  The inside diameter of the boron sphere 
is approximately 2.8 cm (1.1 in).  The outside diameter is approximately 4.75 cm (1.9 in).  The
boron sphere assembly was placed in the center of the foil positioning plate. as shown in Figure 
5b.
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Figure 6.  Boron sphere used to suppress low-energy neutron flux. 
Use of the foils as described provided 5 basic neutron response functions having a useful degree 
of linear independence.  These response functions were:
1. Resonance capture in the copper, gold, and indium foils in the foil wheel, all with thermal
neutron capture suppressed by cadmium (3 responses); 
2. Total neutron capture in the single uncovered gold foil in the foil wheel (1 response); 
3. Inelastic scatter in the indium foil in the boron sphere (1 response). 
The measurements reported here are based on the results of a one-hour irradiation at a reactor 
power of 770 kW.
Foil Data Acquisition and Analysis 
The irradiated foils were assayed at WSU using a standard high-purity germanium (HPGe) 
gamma spectrometry system (Canberra/Genie). The induced activities in the free-beam foils
were computed from the photopeak areas and system efficiencies based on calibration of the
spectrometer using a National Institute Standards and Technology (NIST)-traceable mixed
europium-antimony calibration source.  The measured activity of the heavy indium foil in the 
boron sphere was corrected for gamma self-shielding using an escape fraction at 336 keV 
calculated using a combination of MCNP computations and handbook data for the specific 
source-detector geometry that was used for the assay.  This factor was 0.90 ± 0.01.  The activity 
of the indium foil in the cadmium cover was taken as the average of the results derived
separately from the measured activities of the three primary gamma lines.
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Deconvolution of the Free-Beam Neutron Spectrum from the Activation Measurements 
The activation rates of the various foils were used to estimate the neutron spectrum by way of a 
simple direct matrix unfolding procedure, derived as follows: 
The volume-average activation rate per atom for a foil dosimeter placed in a neutron flux field 
may be calculated as: 
( ) ( ) dEEER ff Ψ= ³∞0 σ ,        (1)
where σf(E) is the microscopic activation cross section of interest for the foil material, as a 
function of neutron energy and ψf(E) is the volume-average scalar neutron flux within the foil, 
again as a function of energy.  Equation (1) can also be expressed as: 
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where ψ(E) is the unperturbed neutron flux that would exist at the measurement location in the 
absence of the foil and any surrounding spectral modification devices (Cd covers, boron sphere, 
etc.)
It may be noted here that, as a practical matter, the function Pf(E) in Equation 2 can be 
determined independently from Ȍ(E) if desired since it is simply a flux ratio.  In this case Ȍ(E)
on the far right hand side of Equation 2 can be any appropriate a-priori free-beam unperturbed 
flux estimate that is then modified by the self-shielding function Pf(E).
Equation 1 may be written as a summation rather than as an integral by partitioning the range of 
the energy variable into a number of discrete contiguous energy groups:
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where NG is the total number of groups, and 
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( ) dEEj
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ELj ³ Ψ=φ ,        (5) 
where ELj and EHj are the lower and upper limits of energy group j. 
43
If additional foils are placed in the beam, or if a particular foil exhibits more than one activation
response, then Equation (3) may be written as a system of equations: 
jij
NG
j
i aR φ¦
=
=
1
,        (6) 
where Ri is the total activation rate for interaction i, and aij is the activation constant from
Equation (4) for reaction i due to neutrons in energy group j.  There will be a total of NF 
equations, where NF is the total number of activation responses available. 
Effective shielded cross sections ıf(E) and the corresponding shielded and unshielded neutron
fluxes suitable for computing the function Pf(E) in Equation 4 for this work were generated by 
the INEEL using MCNP models of the dosimeter packages in the positioning plate.  The a-priori
unperturbed neutron flux at the center of the source plane, computed using MCNP, was used to 
represent Ȍ(E) in Equation 2.  The MCNP computation for Pf accounts for foil self-shielding as 
well as for the fact that the foils in the outer locations in the positioning plate are exposed to a 
slightly lower flux than they would if they were in the center.
It should also be noted here that in practical applications the functions ıf(E), Pf(E), and Ȍ(E) are 
ordinarily not continuous functions.  For the work reported here they are 47-group 
representations of the actual functions, computed using MCNP and tallied according to the
BUGLE-80 neutron energy structure11.  The integrals in Equations 4 and 5 are therefore actually 
summations over the fine-group structure within each broad group used for spectral unfolding.
The system of activation equations, Equation (6), may be written out in matrix form as: 
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or, more compactly:
[ ] [ ] [ ]RA =Φ .        (8) 
Equation (7) is exact, provided that the reaction rates Ri, the activation constants aij and the group 
fluxes, φj are all self-consistent. If measured reaction rates for each interaction Ri are substituted
into Equation (7), a solution of the resulting new system of equations for “measured” fluxes
corresponding to the measured reaction rates may also be obtained under certain conditions. 
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If NF = NG (as is the case for the measurements presented here), then the matrix [A] is square, 
its inverse will ordinarily exist, and the unknown “measured” flux vector may be obtained by any 
standard solution method that converges, provided that the rows of [A] are linearly-independent. 
In physical terms this implies that the response functions (cross sections) for the activation 
interactions used in the measurement must be selected such that they have different shapes as
functions of energy.  It may be noted that positive fluxes are not guaranteed to result from this 
procedure, but if the elements of [A] are computed in a sufficiently valid, physically-realistic
manner for the specific measurement configuration, and if the measured reaction rates are 
accurately determined, a positive solution can generally be obtained.
Propagation of the measurement uncertainties in the unfolding process can be analyzed as 
follows:
An estimate for the variance of the unfolded flux in group j may be expressed as: 
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,        (9) 
where ui is the experimental uncertainty associated with reaction rate i.  Thus, it is necessary to 
compute a matrix of derivatives of the group fluxes with respect to each reaction rate in order to 
evaluate the uncertainties in the unfolded fluxes from Equation (9).
If the matrix [A] is square, i.e., if NF = NG, as in the measurements presented here, the 
evaluation of the derivatives begins with a rearrangement of Equation (8): 
, (10)[ ] [ ][ ]RC=Φ
where [C] is defined to be the inverse of [A].  Expansion of Equation (10) yields: 
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where NF = NG.     Differentiating with respect to R1 now yields 
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and, in general, 
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Equation (14) describes NF systems of NG simultaneous equations in NG variables that can be 
solved for the necessary derivatives.  These are used to evaluate Equation (9).
The method outlined here, as well as the more general extension to the overdetermined case
where NF > NG, have been implemented in a FORTRAN program SPECTRE, Version 5.2.  This
program inputs self-shielded activation cross section functions ( )Efσ  and the a-priori volume-
average unperturbed and perturbed fluxes, Ψ(E) and , in a user-specified fine-group 
structure for each activation foil interaction of interest.  These, along with a user-input a-priori
spectrum (which in the most rigorous case is the same as Ψ(E), as noted previously) are used to
compute the elements of the matrix [A] for NG broad groups, each of which spans one or more
specified fine groups.  Solution of the various systems of equations to produce the unfolded 
fluxes and associated uncertainties corresponding to a user-input set of NF measured activation 
rates (and associated experimental uncertainties) is accomplished using standard Gauss-Seidell
iterations, with linear extrapolation to accelerate convergence.
( )EfΨ
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RESULTS
The measured saturation activities of the various foils are shown in Table 2.  The statistical 
uncertainties given in this table include the uncertainty of the spectrometer calibration as well as 
the uncertainty of the activity measurement for each foil.  These were used to derive the 
spectrum of the neutron flux at the measurement location using the previously-described direct
few-group matrix unfolding procedure.
Table 2.  Foil saturation activities measured at a WSU reactor power of 770 kW.
Neutron Interaction Saturation Activity4
(Bq/ atom)
197Au (n, Ȗ)1 4.02 x 10-14  ( 5.0%) 
115In (n, Ȗ)2 5.02 x 10-14  ( 5.1%) 
197Au (n, Ȗ)2 3.52 x 10-14  ( 5.0%) 
63Cu (n, Ȗ)2 1.44 x 10-16  ( 5.6%) 
115In (n,n')3 2.80 x 10-19  (5.2%) 
1   Bare foil. 
2   Cadmium covered foil. 
3   Foil in boron sphere. 
4   Percentage uncertainty (1ı) given in parentheses.
Figure 7 shows an unfolded, 5-group, free-field, unperturbed neutron spectrum in the source 
plane, at the center of the foil positioning plate.  The computed 47-group a-priori neutron 
spectrum, normalized to 770 kW, is also shown in Figure 7 for comparison.  The broad group 
structure used for the unfolded spectrum presented in Figure 7 was selected to provide a well-
conditioned unfolding matrix, and because it permits the most accurate integration of the
measured spectrum in the epithermal energy range to determine the total epithermal neutron flux.
It will be observed that the propagated uncertainty associated with the thermal flux (E < 0.404 
eV) in Figure 7 is quite large.  This is a result of the fact that the thermal flux is very small
compared to the remainder of the spectrum.  The measured activities of the gold foils with and
without Cd covers differ by only a few percent --- a difference comparable to the uncertainties of 
the activities themselves.  This leads to a magnification of the uncertainty in the usual manner
when the thermal flux is estimated from these foil activities in the spectral unfolding process. 
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Figure 7.  Unfolded free beam neutron spectrum in the source plane obtained by direct fitting for 
the WSU epithermal neutron beam facility.  The reactor power was 770 kW. 
Integrating the measured curve shown in Figure 7 between the standard epithermal energy limits
of 0.414 eV and 10 keV produces a measured epithermal neutron flux of 4.1 x 108 n/cm2-sec at 
770 kW, with a propagated uncertainty of approximately 5% (1ı).  This is well within the 
expected range based on the design computations. It may be noted that this flux is expected to
increase by a factor of between 2 and 3 when the WSU reactor fuel element loading pattern is 
reconfigured for optimum beam performance.
A simple, but widely used metric for the quality of reactor-based epithermal-neutron beams is 
based on dividing the free-field neutron KERMA rate of the beam (integrated over all energies
above thermal) by the useful epithermal-neutron flux, again measured in the free field.  This 
parameter is an indicator of the non-selective neutron background dose that will be produced in
tissue by the above-thermal spectral component of the beam itself, in the absence of any neutron 
capture agent that may be administered to the patient.  It is computed here for WSU using the 
measured flux spectrum in conjunction with broad group KERMA factors based on data for the 
components of standard tissue available on File 27 of the BUGLE11 cross section library that was 
used for the various DORT computations performed as part of this project.  Fine-group neutron 
KERMA factors from File 27 are averaged over the broad unfolding group structure using the a-
priori spectrum as a weighting function to produce the necessary information.  This procedure 
yields a measured free-beam neutron contamination parameter of 2.96x10-11 cGy total neutron 
KERMA from all components per unit useful epithermal-neutron flux, with an estimated
uncertainty of about 7%.  This is in excellent agreement with the computed value of 2.75 x 10-11
cGy-cm2.  Approximately 91% of the background neutron dose results from proton recoil.  The 
remainder is from other recoil components.  Additional background dose in tissue is, of course, 
produced by non-selective thermal neutron induced components, primarily from neutron capture 
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in nitrogen and hydrogen, but these components are not directly indicative of the intrinsic 
biophysical quality of the incident beam.  They must be taken into account in treatment planning, 
but they are not normally included in the free-beam quality parameter discussed here.
DISCUSSION
The WSU facility is the third clinical-scale reactor-based epithermal-neutron source for BNCT 
research that has been constructed in the U.S.  With the recent decision to decommission the 
Brookhaven Medical Research Reactor, the new WSU neutron source and a recently constructed
epithermal beam facility at the Massachusetts Institute of Technology12 are the only two 
currently operating reactor based facilities of this type in the U.S. 
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INTRODUCTION
The Idaho National Engineering and Environmental Laboratory (INEEL) has long been active in 
development of advanced Monte Carlo-based computational dosimetry and treatment planning 
methods and software for advanced radiotherapy, with a particular focus on Neutron Capture 
Therapy (NCT) and, to a somewhat lesser extent, Fast-Neutron Therapy (FTN).  The most recent
INEEL software system of this type is known as SERA, Simulation Environment for
Radiotherapy Applications1.  SERA is at a mature level in its life cycle, it has been licensed for 
research use worldwide, and it has become well established as a computational tool for research. 
However, along with its strengths, SERA also has some limitations in its structure and 
computational methodologies.  More specifically, it is optimized only for neutron-based 
applications.  Although photon transport can be computed with SERA, the simplified model that 
is used is designed primarily for photons produced in the neutron transport process.  Thus, for
example, SERA is not appropriate for applications to standard external-beam photon 
radiotherapy, which is far more common in the clinic than neutron based therapy.
At the same time, researchers at Lawrence Livermore National Laboratory (LLNL) have been 
engaged in the development of the PEREGRINE Monte Carlo code system, optimized for photon 
and electron therapy2. Now, as a logical next step in the development of modern radiotherapy 
planning tools to support the most advanced research, INEEL and LLNL have recently launched 
a new project to collaborate in the development of a “next-generation” multi-modality treatment
planning software system.  This effort will draw on the combined experience of the two 
laboratories, in their respective areas of interest to produce a new system that will be useful for
all modern forms of radiotherapy.  This article first provides some history of the SERA and 
PEREGRINE systems, followed by a discussion of the more recent new developmental effort 
being undertaken by INEEL and LLNL, along with a summary of current progress.
51
HISTORICAL BACKGROUND
INEEL
Figure 1 shows, on the left-hand side, a history of the medical treatment planning software 
developmental effort at the INEEL, which has been focused almost entirely on neutron-based 
applications.
Figure 1.  History of radiotherapy planning software development at the INEEL and at LLNL. 
In the 1980s, it became apparent that new computational methods were required to support large 
animal-model preclinical NCT research, and anticipated human trials, for epithermal-neutron
NCT in the U.S.  Computational approximations that work well for photon-electron therapy and, 
to some extent, fast-neutron therapy, are not appropriate for neutron capture therapy.  Complete 
solutions of the transport equations, with an explicit treatment of particle scattering, are required. 
Standard Monte Carlo radiation transport codes used in other fields of nuclear science, e.g., 
MCNP3, have often been used successfully for this purpose by various investigators.  In addition,
specialized medical image-based geometric reconstruction and radiation dose visualization 
interfaces have been introduced for use with an especially tailored version of MCNP to produce
a practical treatment planning system for boron neutron capture therapy (BNCT)4,5.  Modern, 
three-dimensional, general-purpose discrete-ordinates codes have also sometimes been used to
perform the necessary calculations6,7.
However, MCNP and other general-purpose transport codes are designed for very broad 
applications.  They are quite flexible, and have the advantage of dedicated maintenance and
quality control by the developers, but in some situations they can tend to be slow in execution,
52
relative to expectations for treatment planning in clinical oncology practice (a few minutes per
field, maximum), and there are limitations in the geometric detail that can be modeled.  Hence, a 
project was initiated at the INEEL in 1988 to develop a special-purpose, medical image-based
Monte Carlo system optimized specifically for radiotherapy, with epithermal-BNCT as the first
anticipated application.  This initial effort, conducted in collaboration with the University of 
Utah Department of Computer Science, resulted in the BNCT_edit system8 as shown at the top 
of Figure 1.  BNCT_edit was used by the INEEL in the early 1990s for various preclinical 
applications, but it was not used for human trials and it was never released for external use.
In 1994 BNCT_edit was replaced by a much-improved system, BNCT_rtpe (BNCT Radiation 
Treatment Planning Environment).  The BNCT_rtpe system was introduced into clinical use in 
connection with the Department of Energy (DOE)-sponsored clinical trials of epithermal-neutron
BNCT for glioblastoma multiforme that began at Brookhaven National Laboratory in the same
year9.  BNCT_rtpe was developed by the INEEL in collaboration with the Montana State 
University (MSU) Department of Computer Science.  It was based on experience gained with the 
BNCT_edit development effort, in that it featured a sophisticated Non-Uniform Rational B-
Spline (NURBS) approach to image modality-independent reconstruction of patient geometry
from medical images10.  With this method, the patient anatomy is initially reconstructed in so-
called “pixel space,” with subsequent rescaling to the actual computational geometry using the
true field of view parameters pertinent to the image set.  This allows modeling of essentially any 
anatomy that can be imaged, independent of the image modality, and without any computational
restrictions.  Furthermore, it incorporated an improved particle tracking method11 based on a 
superimposed “edit mesh” that offered relatively rapid computation times (2-4 hours per field on 
the computer hardware of the time) compared to what had been previously possible, and vastly 
improved user interfaces.  In addition to the Brookhaven application, BNCT_rtpe was also 
licensed for use in the European BNCT research programs conducted by the Technical Research 
Centre of Finland, and by the Commission of the European Communities Joint Research Centre 
at Petten, in The Netherlands.
Although BNCT_rtpe proved to be a useful and relatively efficient clinical research tool, there 
still was a need to reduce the computation time further-ideally to no more than a few minutes per
field.  Accordingly, INEEL and MSU undertook some studies in the late 1990s that were focused 
on achieving a significant breakthrough in execution speed via a total reformulation of the 
mathematical algorithms.  Although it is possible to recast various standard Monte Carlo 
algorithms for parallel execution on specialized multi-CPU computer systems and thereby
achieve increases in execution speed, INEEL and MSU researchers instead directed their efforts 
toward development of new and much faster algorithms.  This approach was taken because most
radiotherapy research centers and clinics typically operate with single-CPU desktop computer
systems.  The result of this developmental effort led to the introduction of the completely new
SERA1 treatment planning software in 1998. 
The SERA treatment planning system incorporates an integrated method for reconstructing 
patient geometry from medical images and for subsequently tracking particles through this 
geometry during a Monte Carlo radiation transport simulation.  The method, in contrast to coarse 
voxel reconstruction methods used with standard transport codes and the NURBS method used 
in BNCT_rtpe, is based on a pixel-by pixel uniform volume element (“univel”) reconstruction of 
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the patient geometry12.  As with the B-Spline method, construction of the patient geometry is 
independent of the medical image modality and field of view.  Anatomical regions are defined on 
a selected set of two-dimensional images, and these regions are combined to produce a three-
dimensional (3D) reconstruction, as shown in Figure 2.  Fast scan-line rasterization methods,
implemented largely with integer arithmetic, are then used to allow rapid particle tracking
through the univel geometry.  This is a key distinction between the univel method and standard 
voxel based reconstruction and tracking methods.  Univels along the particle track are
investigated and precise intersection points (“distance to boundary” in Monte Carlo terminology)
can be rapidly calculated as the particle moves from one anatomical region to the next.  Fluxes
and doses are then tallied on a superimposed edit mesh in the same manner as in BNCT_rtpe.
The univel method has several attractive features.  By scaling the univels to match the resolution 
of the original image data, the geometric fidelity of the NURBS reconstruction method is
retained, but certain numerical difficulties associated with defining non-intersecting volumes in 
regions where the spline surfaces are very close together are eliminated. Furthermore, and most
visibly, the computed fluxes and doses have the same statistical accuracy as with a NURBS 
model, but the execution time for the transport computations is reduced by a factor of between 
five and ten.  This speedup factor holds even though the new univel model may consist of several 
million elements.  Single-CPU execution times for SERA, with current desktop scientific
computing hardware (e.g., 750 MHz Pentium III systems running under Linux), are in the
range of a few minutes per field for neutron applications. 
Figure 2.  Univel-based anatomical reconstruction in SERA, with three-dimensional dose 
display.
Finally, the basic physics modules of SERA allow incident neutron energies up to 100 MeV, 
with an explicit (i.e., non-equilibrium) treatment of recoil proton transport13.  This expands the
utility of the SERA system into the field of FNT, with NCT augmentation14.  Although other 
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clinically-useful treatment planning methodologies and tools are available for FNT15, these are 
based on approximations, whereas SERA offers the capability to rigorously handle the more
complex neutron transport and thermalization computations required for combined FNT/NCT 
applications.
SERA is licensed worldwide for research purposes and is currently in clinical testing in
connection with ongoing epithermal-neutron BNCT clinical trials in Finland, Sweden, and in The
Netherlands.  Active SERA licensees include:
Lawrence Berkeley National Laboratory 
The University of Washington
Massachusetts Institute of Technology 
 Purdue University
Commission of the European Communities – Joint Research Centre Petten
The Technical Research Center of Finland 
Helsinki University Central Hospital
University Hospital Birmingham (United Kingdom)
Commision Nacional De Energia Atomica (Argentina)
Studsvik BV (Sweden)
 Lund University (Sweden)
Kyoto University (Japan)
Medical Radiological Research Center, Russian Academy of Medical Sciences 
Institute of Physics and Power Engineering (Russia) 
National Tsing-Hua University 
SERA licensees have agreed to serve as benchmarking and testing institutions for SERA.  They 
have provided, and continue to provide, extremely valuable feedback and suggestions for 
improvement.  SERA is maintained by the INEEL and MSU via an internet-based update
distribution.  It is anticipated that SERA will be maintained in a reasonably stable configuration
for the foreseeable future, as shown on the left-hand side of Figure 1. 
LLNL
Figure 1 shows, on the right hand side, the history of the PEREGRINE code at LLNL.  The 
PEREGRINE dose calculation system2 is primarily designed to provide Monte Carlo transport
calculations fast enough for day-to-day external-beam photon-electron radiation therapy
planning, although computations for other types of radiotherapy using specialized versions of 
PEREGRINE are also possible.  It operates on low-cost commodity hardware, enables real time
visualization of dose as it is simulated, and completes a full treatment simulation in minutes.
PEREGRINE simulates radiation therapy starting with a set of representative particles randomly
sampled from energy, angle, and position distributions determined from offline simulations of
the treatment-independent portion of the radiation source.  It tracks each photon, electron, and 
positron through the treatment-dependent beam delivery system and then through the patient 
using random numbers, microscopic particle-interaction probabilities, and other standard Monte 
Carlo transport methods.  As each particle interacts, it sets in motion other particles that are also
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tracked. Photons and electrons are tracked to a minimum energy of 10 keV.  The minimum
energy for delta ray and bremsstrahlung production is 200 keV. 
Treatment-specific beam modifiers, such as collimators, apertures, blocks, multileaf collimators
and wedges, are modeled explicitly during each PEREGRINE calculation.  Each component is 
described in terms of its physical dimensions, material composition, and density.  The patient is
described as a Cartesian map of material electron density determined from the patient’s
computed tomography (CT) scan.  Each CT pixel defines the electron density of a corresponding 
transport mesh voxel.  Material composition is determined from user-defined CT threshold 
values.  Density is determined from a user-defined, piecewise-linear function that describes the
CT number-to-density conversion.  PEREGRINE records the dose deposited by each particle in a 
uniform Cartesian dose collection mesh that consists of packed spheres. 
The PEREGRINE dose calculation system demonstrates the promise of Monte Carlo modeling
for photon-electron radiation therapy.  The value of stochastic simulations stems from the ability 
to use basic, microscopic physical data to provide practical information in arbitrarily complex
systems.  This power is limited only by the computational time necessary to complete
sufficiently precise calculations and the creativity of the analyst.  Many typical computations can 
be completed in minutes on hardware designed for clinical treatment planning, and faster 
computers will allow continued progress.
As is the case with SERA, PEREGRINE is in a relatively mature, stable status.  The current
release version, recently licensed for commercial applications by the NOMOS Corporation, has 
been approved by the U.S. Food and Drug Administration (FDA).  It is anticipated that
PEREGRINE will remain in a stable configuration to facilitate clinical deployment for external
beam photon-electron therapy, as shown on the right-hand side of Figure 1. 
THE MINERVA PROJECT
With SERA on a path to stabilization, INEEL and MSU began directing their attention to the 
development of a new generation of radiotherapy planning software, with a much broader range 
of applications in mind.  More or less concurrently, the developers of PEREGRINE were
thinking along the same lines.  As a result, INEEL, MSU and LLNL launched, in October, 2001, 
a new project to collaborate in the creation of a multi-modality treatment planning software
system that will draw on the combined experience of the two laboratories in their respective
areas of interest.  It will feature several important new functionalities made possible by recent 
advances in computational hardware, software, and operating system technology. The objective 
will be to create an integrated software system that is useful for all modern forms of
radiotherapy.  The new system will carry the name MINERVA (Modality-Inclusive Environment
for Radiotherapeutic Variable Analysis).
Several state-of-the-art features will be incorporated into the new system, which is shown 
schematically in Figure 3. With the advent of the Javaa internet-based programming language, it 
is now possible to produce extremely sophisticated software and graphic user interfaces with 
much greater portability among various computer hardware platforms.  In addition, the focus will 
a  Java is a trademark of Sun Microsystems, Inc.
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be on the development of a system that can be easily tailored to any radiotherapy modality, and 
to include multiple computational methodology options for a given therapeutic modality via an 
open “plug-in” based interface environment.  The first version of MINERVA will include
capabilities for external beam photon, electron, fast-neutron radiotherapy, neutron capture 
therapy, and molecular targeted radionuclide therapy.  Other future anticipated additions include 
computational modules optimized for external-beam proton therapy, as well as for 
brachytherapy.  Alternate computational methods based on existing transport software, such as 
MCNP, could also be incorporated by providing an appropriate code specific interface, as shown 
in Figure 3.  The new system will employ multi-modality image sets for treatment plan
development, and it will implement a universal data base for patient information file storage,
with interfaces to accommodate standard clinical data communication protocols and formats,
such as RTOG and DICOM-RT. 
Figure 3.  Schematic of the MINERVA code system.
The following three sections detail the recent progress and the current status of various aspects of 
the MINERVA project. 
Feasibility Investigations --- The Seragrine Prototype System
In anticipation of this longer-term joint developmental program, INEEL and LLNL have 
completed some initial computational feasibility studies for a combined software system.  These 
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studies employed an internet-based, ad hoc coupling of the functionalities in the SERA and 
PEREGRINE code systems as they currently stand to produce a temporary prototype, referred to 
as Seragrine.  (See accompanying article in this report, P. 69).  This exploratory system will 
continue to be used, on an interim basis, for various studies required to specify the design of the
new system.  The final product will be almost entirely based on new code, but the exercises 
conducted here have successfully demonstrated that there should be no fundamental difficulties
with the development of the key computational and data interfacing functions that will be
required in the new system.  Two specific demonstration computations have been completed in 
this manner:
1. Calculation of the radiation dose distribution in a hypothetical patient resulting from a 
manually specified, spatially distributed, radionuclide-based internal photon-electron source. 
2. Calculation of the radiation dose distribution in a hypothetical patient resulting from the
application of photon and electron beams.
Dose Distribution from an Internal Radionuclide Source - PEREGRINE and SERA are not
currently well structured for calculations involving fixed internal radiation sources.  Secondary 
particles created by the interaction of external radiation sources within the patient anatomy are, 
of course, properly accounted for in both systems, but primary internal sources are not routinely 
accommodated.  To handle this on a temporary demonstration basis, a special auxiliary univel
file was created for use with SERA where the material specification for each univel was
interpreted not as a physical material, but as an internal radiation source intensity (Bq per unit 
volume) averaged over the univel volume.  For this application the source was assumed to be 
131I, and the spatial distribution was assumed to be uniform over a target volume that is typically 
associated with Glioblastoma Multiforme at presentation.  This pseudo-univel file could be
superimposed in SERA over the medical images used for the actual anatomical reconstruction, as 
shown in Figure 4, to show the assumed radionuclide distribution. The patient geometry for this 
demonstration was based on CT images taken from the Visible Human (VHP) data set 
distributed by the U.S. National Library of Medicine (http://www.nim.nih.gov).
Figure 4.  Radionuclide distribution superimposed over patient anatomical image.
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The file describing the radionuclide distribution and the corresponding VHP anatomical image
set were then passed to PEREGRINE for the photon-electron radiation transport computation.
The resulting radiation doses were then passed back to SERA for contouring and display,
superimposed over the original anatomical image set.  The resulting dose contours (at intervals 
of 10%) for one axial plane are shown in Figure 5. 
Dose Distribution from an External Photon-Electron Teletherapy Source - Figure 6 shows a 
case in which PEREGRINE was used to compute dose distributions resulting from application of
standard external 6 MeV photon beams to a patient represented by the VHP anatomical data set. 
The resulting dose maps were then input to SERA for processing and display.  The photon beam
results shown here result from full photon-beam models.  Figure 7 shows a dose distribution
resulting from a monoenergetic 8 MeV electron point source.  Once again, the ability to couple 
the functionalities of PEREGRINE and SERA is clearly demonstrated.
Figure 5.  Total dose contours computed by PEREGRINE for the demonstration targeted 
radionuclide source. 
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Figure 6.  Dose contours resulting from a multi-field external photon source. 
Figure 7.   Dose contours from an external electron source. 
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Development of the Computational Module for Coupled Photon-Electron Transport 
The initial emphasis in this part of the project has been focused on working with prospective 
users to assess the roles and key challenges in treatment planning for emerging photon/electron 
radiation therapy modalities16,17.  From this, the overall functional requirements of the system for 
internal and external radiation sources have been developed, with an emphasis on internal 
radioisotope emitters, including the input of radiation source distributions from planar (2D) and 
single photon emission computed emission tomography (SPECT) (3D) scans18,19.  In addition, 
the development and testing of the MINERVA photon-electron particle transport package, which 
is based on the PEREGRINE system, continued, with extensions of its capabilities to internal
isotopic emitters18 as described previously. 
The initial validation approach for internal isotopic sources has been the comparison of 
MINERVA transport module simulations with other well-benchmarked Monte Carlo code 
systems and standard publications for point and spherical-volume sources consisting of 
monoenergetic photons and electrons, as well as commonly-used isotopes.  The first phase of this 
benchmarking effort is complete.  It was generally observed that MINERVA simulations of 
absorbed fractions for monoenergetic, photon and electron radiation sources distributed 
uniformly in standard tissue and water spheres agree with EGS420 to about 2% and MCNP3 to
about 5%, for sphere radii ranging from 1 to 7 cm for electrons, and 1 to 10 cm for photons.  In 
addition, MINERVA simulations of absorbed fractions for photons emitted by 131I, 111In, 67Cu,
and 186Re agree with EGS421 to within 1-2% for sphere radii ranging from 1 to 15 cm. For
monoenergetic photon sources, MINERVA, EGS4, and MCNP predict absorbed fractions that 
are higher than those recommended by MIRD-322 and MIRD-823, by as much as 30-40%. 
Development of User Interfaces
TIRADE (Transport Independent RADiotherapy Environment) was introduced in the INEEL 
BNCT Research Program Annual Report 200024 as a generalized multi-modality treatment
planning system.  With the incorporation of LLNL into the developmental effort as of October 1,
2001, the MINERVA name was adopted for the overall software system.  However, since the 
initial development of the common interface modules and tools was performed under TIRADE 
acronym for the first three quarters covered by this Annual Report, the TIRADE acronym is 
retained in this section for this year only. 
As detailed previously, MINERVA is designed to accommodate the differing modalities via 
plugins through the application programmer's interface (API).  Each plugin, whether for a source
specification module or transport application, will provide its own graphical user interface 
(GUI).  For the targeted radionuclide modality, MSU/INEEL will be developing the source
specification module, and LLNL will be developing the transport plugin as well as specifying 
interfaces and dose reporting requirements.
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Patient Module - The patient module, the focal point of the system shown in Figure 3, manages
the entire treatment planning process.  In addition to running and managing all of the
independent modules, the patient module creates, edits, and retrieves patient information.  The
ability to access the new patient database has been added to the patient module in CY 2001.
Image Processing Module - The image module is at the beginning of the treatment planning 
pipeline.  It prepares and processes the images for use by the other TIRADE modules.  During 
the last year, an image registration system based on the use of mutual information25 to determine
the best 3D fit between two image sets was completed.  This method is marker-independent and 
relies only on the content of the images to produce a registration, making it easier for users and 
less invasive for patients.  More importantly, patients that are imaged, either without markers, or 
with a non-standard marker system, all can have their image sets registered.  The optimal fit is 
based on a line optimization with parabolic interpolation to improve the speed and reduce the 
likelihood of being side-tracked by local minima.  This system is currently being tested and 
refined for integration into the image module.
A filter was added to the image module to remove the random noise from an image so that the
outer edges are more sharply defined, and image noise and unwanted information are removed in 
the space outside of the image object.  This should improve the accuracy and performance of the 
image registration algorithm, particularly when working with images from positron emission
tomography (PET) scanners. 
Anatomical Modeling Module - The modeling module provides tools for creation of the 
anatomical geometry of the patient and target based on the image data.  The model module is 
used to either create a new univel geometry file or edit an existing model.
During CY 2001, several changes were made to the modeling module.  Several programming
errors were corrected.  To facilitate modeling, a 3x3x3 median filter was added to better define 
structures within an image.  This filter treats each image pixel as having an intensity value equal
to the average of the pixel and its 26 nearest neighbors in three dimensions, which smoothes the
intensity distribution and improves the threshold functionality.  The ability to save and load data 
into and out of the database was added to the model module.
Reporting and Display Modules - Formerly, the SERA reporting module included two 
separate interfaces:  the plotting module and the dose module.  The plotting module provides the 
functionality for displaying, comparing, and manipulating dose-volume histograms (DVH) and
dose-depth plots (DDP).  The dose module allows the user to load and display contours on 
individual images and entire image sets.  Over the past year, the plotting and dose contouring 
modules were integrated into a single interface.  The decision to combine plotting and 
contouring functionality will allow the development of tools that better show the relationship
between DVH and DDP and the contours displayed on the image sets. 
Currently, the display module is in the early stages of development, but will eventually provide
the user with powerful tools to compare and assess the treatment plans generated by the modules
in the TIRADE treatment planning pipeline. 
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Figure 8 is an example of a dose volume histogram using the display module.
Figure 8.  TIRADE display of dose-volume histogram.
Three-Dimensional Methods - Several 3D classes and methods have been developed, including 
methods to display, scale, and rotate 3D objects using the mouse or keyboard.  A 3D geometry
class has been created for displaying image, geometry, and dose data.  The methods of the
geometry class can display the geometry data as points, lines, and polygons, similar to that which 
was provided in SERA.  The geometry class also allows the user to specify which regions to 
display, and the attributes (color, transparency, etc) used to display these regions.  This class can
be added to the image, model, and reporting modules to display the appropriate data.
Design and Development Tools
The system is being designed with the Unified Modeling Language (UML) and coded with the 
Java26 language.  Researchers have examined two new Java design and development tools, 
Together Control Centera and NetBeansb, which are described in the next two subsections. 
While the design and development policies do not require the use of these two tools, they are 
highly recommended.  Coding standards and policies can be found at the developer's web site, 
which is described in the last section of this particular report. 
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a TogetherSoft is a trademark of TogetherSoft Corporation (www.togethersoft.com)
b Netbeans is a Trademark of Sun Microsystems  (www.netbeams.org)
Unified Modeling Language / Together Control Center - The UML has been used extensively
in the design and development of the TIRADE project.  During the past year, the Together 
Control Center software package for UML modeling and diagramming has been used 
extensively.  This software uses the UML specifications for creating diagrams showing the 
relationships between packages, classes, and objects.  Together Control Center also provides 
CVSa support and the capabilities to generate source code templates directly from diagrams,
generate diagrams for code already written, and generate project documentation and diagrams in 
hyper-text markup language (HTML) format.
NetBeans - The NetBeans Integrated Development Environment (IDE) is a software package
that combines many useful development tools for Java, such as a source code editor, compiler,
and debugger, into one piece of software.  NetBeans software was chosen as the recommended
development environment for the TIRADE project because, along with basic IDE tools, it offers 
many useful features, such as CVS support, JavaDoc index searching, and the ability to create 
source code templates.  NetBeans is an open-source project written entirely in Java, which makes
it platform independent and easily obtainable by everyone involved in the TIRADE project.
Database
Database support has been added to the patient, image, and model modules.  The database part 
of TIRADE has undergone significant redesign in the last four months of CY 2001.  Even the 
understanding of how Java applications use the Java Database Connectivity (JDBC) to access 
information stored in a database has changed.  Previously, it was understood that all Open 
Database Connectivity (ODBC) compliant Database Management Systems (DBMS) wrote their 
files to a common specification, allowing one DBMS to read database files produced by any 
other ODBC compliant DBMS.  In practice, only the DBMS that wrote the database is able to 
read it (see Figure 9).  Several database drivers (MySQL, Postgress) will be supported. 
Currently, tools are provided to exchange information among supported databases.  TIRADE 
will also provide the capability to export the database information to flat files.
Steps have been taken to ensure that the database integrity is maintained by storing a patient's
information in several smaller tables and by supporting transactional tables.  The latter guards 
against a patient's data being partially updated during a save and therefore corrupted.  If, for 
some reason, data corruption did occur, the damage would be largely localized through the 
database design. 
The main focus of database development during the reporting period has been developing a 
common set of tools for accessing the database.  One of these is a tool that will convert the 
database to flat files and back again.  This ability is provided for transport plugin developers who 
prefer to read and write flat files. 
Transport Plugins 
Development began on a tool to calculate digitally reconstructed radiographs (DRR) from the
patient  anatomical  model.  A DRR  is  simply a  projection of  monoenergetic,  monodirectional
a Concurrent Version System, freeware (see reference 28).
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Figure 9.  TIRADE database design. 
photons from a plane source through the patient geometric model.  The resulting images are 
useful for various verification processes in treatment planning. The photon transport model used 
was a simple attenuation function, which assumes that any interaction results in a loss of the
photon.  This methodology also has applications for molecular targeted radiotherapy, as the 
calculation engine for attenuation correction of initial internal source distributions in a semi-
iterative approach.  Requirements for this module will be developed with guidance from LLNL. 
The TIRADE DRR tool was developed using both the Java and C programming languages to 
compare language dependent performance.  The Java version achieved 50% to 66% of the speed 
of the optimized C version in our tests.  This, along with evidence that IBM has achieved 90% of 
the speed of optimized Fortran in their Watson Research Center NINJAa project for certain
BLASb routines, suggests that Java may be a viable candidate language for developing 
numerically intense transport applications as well as for visualization applications.  This presents 
certain advantages over conventional software development and deployment using C and/or 
Fortran, as Java is inherently more portable, and the resulting transport plugin can then be more
easily integrated into the TIRADE system (e.g., direct database access.)  With this in mind,
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a Numerically Intensive Java (http://www.research.ibm.com/ninja/)
b  Basic Linear Algebra Subprograms
design of the neutron transport module for the MINERVA package has begun, with the intent of 
developing the code using the Java programming language and the development methods
outlined in Section 2 above.
Website
The developers' website (http://boron.csnet.montana.edu) for the INEEL/MSU Advanced
RadioTherapy Project (ARTP) was created to provide documentation, programming standards, 
and design information.  This website includes the CVS repository mailing list archives, which
allows browsing of the changes made to the TIRADE source code and data.  The ARTP website 
contains links to the TIRADE development resources, including the TIRADE JavaDoc and UML
diagrams and documentation.  Also included is bugzilla (http://www.mozilla.org/bugs/), a bug 
tracking database.  Bugzilla allows bugs to be recorded, annotated, assigned, and resolved. 
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MOLECULAR TARGETED RADIOTHERAPY 
DEMONSTRATION SOFTWARE 
C.A. Wemple 
Idaho National Engineering and Environmental Laboratory, Idaho Falls, ID
INTRODUCTION
As part of the Idaho National Engineering and Environmental Laboratory/Lawrence Livermore
National Laboratory (INEEL/LLNL) radiotherapy software development collaboration, a 
demonstration tool was required to verify that molecular targeted radiotherapy (MTR) dose 
distributions could be calculated in the PEREGRINE1 code.  This tool should allow processing 
of medical images, designation of anatomical structures on the images, assignment of 
radionuclides to multiple organs, and display isodose contours on the medical images, with data 
passed in a form compatible with that employed in PEREGRINE2.  The SERA code system3
already provided many of these tools, so it was seen as a logical starting point for development
of such a demonstration tool.  Thus, in order to provide a testbed for future developments, and 
enable development of the MTR calculation mode, a modified, special purpose version of the 
SERA code was created to provide a link to the PEREGRINE code.  The name adopted for this 
demonstration tool was Seragrine. 
SERA MODIFICATIONS 
Several modifications were required to the SERA modules, mostly involving reading and writing 
data in forms compatible with PEREGRINE.  First, the Image, Model, and Dose modules needed 
to read medical images in the PEREGRINE format, and the Image module needed to also write 
them in this form.  The Dose module had to be modified to read and process the PEREGRINE 
dose formats.  The Model module required modifications to assign radionuclides to various body 
structures, and write the resulting univel4 data as an activity map for PEREGRINE.  An 
additional parameter was defined in the body_data structure within the Model module, to allow 
the user to define the uniform radionuclide concentration in a given structure. 
EXPERIENCES
Initial testing of the Seragrine tools was performed using a uniform radionuclide concentration in 
the tumor region only for a standard test image set with an artificially created tumor region. 
Dose results for calculations with a concentration of 0.17 Ci/g of 131I in the tumor are 
displayed Figure 1.  Testing of cases with the radionuclide deposited in multiple, disjoint 
locations is presently underway at LLNL. 
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Figure 1.  Dose results for calculations with a concentration of 0.17 Ci/g of 131I in the tumor.
CONCLUSION
The capability to perform MTR dose calculations using a demonstration tool, Seragrine, has 
been successfully developed and exhibited.  This will form the experience basis for future
development of more sophisticated tools, under the auspices of the TIRADE portion of the 
program.
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FILTERED EPITHERMAL PHOTONEUTRON BEAM PARAMETER 
STUDIES FOR NEUTRON CAPTURE THERAPY APPLICATIONS 
D.W. Nigg1, C.A. Wemple1, W. Scates2, and J. F. Harmon2
1.  Idaho National Engineering and Environmental Laboratory, Idaho Falls, ID 
2.  Idaho State University, Pocatello, ID 
INTRODUCTION
The Idaho National Engineering and Environmental Laboratory (INEEL) has been investigating 
the feasibility of a concept for an accelerator-based source of epithermal neutrons for Boron 
Neutron Capture Therapy (BNCT) and other applications that is based on the use of a two-stage 
photoneutron production process driven by an electron accelerator1.  In this concept, shown in 
Figures 1 and 2, electron beams impinge upon heavily shielded tungsten targets located at the 
outer radius of a small cylindrical tank of circulating heavy water (D2O), possibly with a 
beryllium insert to enhance the neutron yield. A fraction of the energy of the electrons is 
converted in the tungsten targets into radially-inward directed bremsstrahlung radiation. 
Neutrons subsequently generated by photodisintegration of deuterons in the D2O and Be within 
the tank are directed to the patient through a suitable beam tailoring system.  The entire assembly
could be constructed as part of a standard, shielded, hospital radiotherapy facility.  The activities 
described in this article represent the completion of a multi-year INEEL effort, in collaboration
Figure 1.  Artist’s conception of the epithermal photoneutron source concept for BNCT. 
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Figure 2.  Schematic design of the epithermal photoneutron source concept for BNCT. 
with the Idaho Accelerator Center (IAC) at Idaho State University (ISU), to experimentally
demonstrate the feasibility of the concept using a realistic prototype.  With some simple design 
changes, the device could also be adapted to the production of thermal neutrons for various 
purposes, including treatment of certain shallow lesions. 
Initial proof-of-principal tests using a low-current, benchtop prototype of the filtered
photoneutron source concept were conducted in 1994 and 1995.  Testing included extensive 
measurements of the unfiltered photoneutron source2, as well as initial measurements of filtered
epithermal-neutron spectra produced using two different advanced neutron filtering
assemblies3,4. In the early experiments, a tunable electron linear accelerator, manufactured by the 
Varian Corporation, was used to drive the experimental apparatus shown in Figure 3.  The 
electron beam energy was established at a nominal average value of 6 MeV with an 
approximately gaussian distribution in energy (FWHMa = 2 MeV).  The forward-peaked 
bremsstrahlung radiation from the tungsten accelerator target was collimated by a cylindrical 
tungsten shield and subsequently directed into a sealed cylindrical LuciteTM container of D2O,
where a well-characterized source of photoneutrons was produced.  Neutron filtering and 
moderating structures were placed downstream of the heavy water photoneutron source region. 
This arrangement would not be typical of an actual clinical device, where the axis of the neutron 
beam would be at right angles to that of the electron beam to reduce photon contamination at the 
patient irradiation point.  For these early experiments, however, it was desired to have a simple
geometry that could be easily modeled in theoretical calculations.  In addition, it was necessary 
to have a high photon flux at the measurement point as an independent quantitative indicator of 
the electron current impinging on the accelerator target, because of difficulties that were 
experienced with obtaining a direct measurement of the current to ground from the target itself. 
a FWHM – full width-half maximum.
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Figure 3.  Early apparatus for filtered photoneutron source experiments.
The neutron filtering and moderating assembly of primary interest was constructed of a 
composite material (69% AlF3, 30% Al, and 1% natural LiF, trade name FLUENTALa),
developed by the Technical Research Center of Finland (VTT)5, and provided for this work to 
the INEEL by VTT under a research agreement. The dimensions of the filter region were 
30x30x40 cm.  The filter thickness along the beam axis was 30 cm.  The measured density of the 
VTT filtering material was 3.01 g/cm3.  The entire filter was surrounded by 2.54 cm of borated 
polyethylene to provide a degree of isolation from room return of neutrons.  A second filter 
assembly, composed of laminated polytetrafluoroethylene (TeflonTM) and aluminum, was also 
tested.
Neutron intensity and spectral measurements using standard resonance and threshold activation 
foil techniques were performed in the early experiments.  The results were generally as expected, 
and it was concluded that the proposed photoneutron device could offer, on the basis of 
neutronic performance, a promising alternate approach to the production of epithermal neutrons 
for BNCT. However, the measurements were performed at rather low electron currents, leading 
to somewhat large uncertainties in the results and, more importantly, the geometry was, by 
intent, not prototypical.  Thus, the next stage of the development effort for this concept was 
focused on construction of a new experimental prototype using a much higher-power L-band 
electron linear accelerator (LINAC) that was concurrently being brought into operation at the 
IAC (Figure 4).  A series of neutronic performance measurements for the new prototype has now 
been completed and the results are presented in this article. 
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a  FLUENTAL is a trademark of the Technical Research Center of Finland. 
Figure 4.  L-Band electron LINAC at the Idaho Accelerator Center. 
METHODS AND MATERIALS 
The new experimental apparatus features a more prototypical system geometry, with the 
irradiation point on an axis at right angles to the electron beam axis.  The higher power of the L-
Band LINAC has permitted neutron spectral measurements with significantly smaller
experimental uncertainties.  Furthermore, the right-angle geometry permits a more realistic 
measurement of the photon content of the source at the irradiation point.  Control of photon 
contamination at the irradiation point is a key to the success of the overall concept. 
Figure 5 shows several steps in the construction of the experimental neutron production and 
filtering assembly.  The accelerator is on the opposite side of the concrete shielding wall in the 
background of Figure 5a.  Electrons from the accelerator are magnetically directed through an 
evacuated drift tube that passes through a hole in the shield wall.  A water cooled tungsten target 
is located at the end of the drift tube, slightly recessed in the hole in the shielding wall (Figure 
5b).  A cylindrical aluminum tank of heavy water, approximately 30.5 cm in diameter and 15.24 
cm in height, is positioned with its curved surface tangent to the wall, in front of the accelerator 
target, as shown in Figure 5c.  Hence, the bremsstrahlung photons produced in the target impinge
radially onto the tank.  The previously-described block of FLUENTAL filtering material, placed 
adjacent to the face of the tank, with the 40-cm dimension aligned perpendicular to the electron 
beam axis, is also shown.  Neutrons emanating from the tank are thus filtered and moderated
through 40 cm of filter/moderator material before emerging on the downstream (in the sense of 
neutron flow) side of the filter-moderator, toward the left side of Figure 5c.  The entire assembly
is surrounded by a reflecting region composed of aluminum oxide and lead blocks, as shown in 
Figure 5d.  Finally, Figure 6 shows a view of the electron drift tube passing into one side of the 
shield wall, with the filter/moderator assembly on the other side. 
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                   (a)                                                                       (b) 
                                        (c)                                                                        (d) 
Figure 5.  Photoneutron production and filtering assembly showing; (a) the shielding wall 
through which the electron drift tube passes; (b) a close-up of the accelerator target assembly; (c) 
a view filtering assembly, with the FLUENTAL filter-moderator blocks on the left (downstream)
side of the heavy water tank; and (d) the complete assembly surrounded by a lead reflector/shield 
region, with aluminum oxide reflector blocks on the back side of the heavy water tank. 
Neutron spectrum measurements were performed using simplified extensions of neutron 
activation analysis techniques6,7 that have been adapted for BNCT applications by the INEEL 
through extensive experience with several other epithermal-neutron facilities in the U.S. and in 
Europe.  Neutronically thick circular foils of various types were used.  The foil specifications 
and corresponding neutron activation interactions of interest are listed in Table 1.
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Figure 6.  View perpendicular to the electron beam axis, showing the shielding wall, the 
accelerator drift tube on the right, and the filter/moderator/reflector assembly on the left. 
Table 1.  Activation interactions and foils used for the filtered epithermal photoneutron 
measurements.
Neutron
Interaction
Nominal
Foil
Mass (g) 
Nominal
Foil
Thickness (cm)
Energy Range of 
Primary Response 
Activation Gamma Energy 
of Interest (keV) 
115In (n, Ȗ) 0.30 0.0127 1 eV Resonance 1293,1097, and 416 
197Au (n, Ȗ) 0.18 0.00254 5 eV Resonance 411
63Cu (n, Ȗ) 8.0 0.2 1 keV Resonance 511 (Positron) 
115In (n,n') 9.0 0.4 430 keV Threshold 336
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Duplicate foils of each type were placed in a borated polyethylene positioning assembly, as 
shown in Figure 7.  The foils were all approximately 2 cm in diameter.  The central cavity of the 
positioning assembly was lined with cadmium.  Indium, gold, and copper foils, as described in 
Table 1, were placed in cadmium covers and arranged around the periphery of the central cavity 
as shown.  Bare gold foils wrapped in aluminum foil were also placed as shown.  A calibrated 
ion chamber with buildup cap (RadcalTM 1510) was placed at the top of the central cavity to 
indicate the photon dose rate at the measurement location.  (This chamber is also somewhat
sensitive to neutrons, but, as will be seen later, the neutron dose rate is significantly smaller than 
the photon dose rate in this particular experimental setup). 
Figure 7.  Detail of foil positioning and shielding assembly.
Finally, heavy indium foils with properties shown in the last line of Table 1 were placed in a 
small hollow boron sphere located in the center of the cavity.  The composition of the sphere is 
approximately 93% 10B and 7% 11B by weight, with a total boron density of 2.6 g/cm3.  The 
inside diameter of the boron sphere is approximately 2.8 cm (1.1 in).  The outside diameter is 
approximately 4.75 cm (1.9 in).  This arrangement provides essentially total suppression of 
thermal and epithermal flux within the inner cavity of the boron sphere.  Thus, an artificial 
threshold above the resonance energy range is imposed on the neutron capture reactions in the 
foil within the sphere.  Since the activation gamma emissions that arise from neutron capture in 
indium are thereby suppressed, the relatively weak 336 keV gamma line from inelastic scatter in 
indium, which is of crucial interest in these measurements, is much more prominent in the 
spectrum of the activated indium foil.  The activated indium foil is also much easier to handle 
when the boron sphere is used in this manner, since the induced activity is significantly lower 
than it would be without the sphere.
Use of the foils as described provided 5 basic neutron response functions with a useful degree of 
linear independence.  These response functions were:
1. Resonance capture in the copper, gold, and indium foils in the foil wheel, all with thermal
neutron capture suppressed by cadmium (3 responses); 
2. Total neutron capture in the single uncovered gold foil in the foil wheel (1 response); 
3. Inelastic scatter in the indium foil in the boron sphere (1 response). 
Figure 8 shows the downstream (in the sense of neutron flow) side of the completed filtering
assembly, surrounded by an aluminum oxide and lead reflector, with bismuth photon shielding 
blocks (thickness = 10 cm) placed on the downstream face of the FLUENTAL neutron filtering 
and moderating region.  The borated polyethylene enclosure for positioning the various radiation 
measuring devices is shown adjacent to the center of the face of the bismuth shielding blocks.
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Figure 8.  Downstream side of the completed neutron filtering assembly, with foil positioning 
shield in place.
The results reported here are for three different average electron beam energies within the 
operating range of the L-Band LINAC.  The three irradiations were designed to obtain data from
about 4 MeV to about 15 MeV to provide a characterization of the system performance as a 
function of electron beam energy, and to thereby experimentally estimate the optimum electron 
energy.  An optimum electron energy, believed to be in the range of 6-10 MeV, will exist since 
higher electron energies produce a higher total neutron yield, but at the same time more high 
energy neutrons are produced.  Thus, additional neutron filtration and moderation is required to 
produce an epithermal neutron spectrum having the desired suppression of the above-epithermal
neutron flux.  The increased filter-moderator thickness that is required with increasing electron 
energy counteracts the higher neutron yield. 
Figure 9 shows the measured electron beam spectra for each of the three irradiations.  These 
spectra were measured by sweeping the electron beam across the target using an analyzing 
magnet and measuring the relative electron current to ground from the target in the usual 
manner. The three average electron beam energies obtained were 4.6 MeV (“Low”), 8.0 MeV 
(“Nominal”), and 11.7 MeV (“High”), with distributions of electron energy about these mean
values as shown in Figure 9.  The spectra have relatively large full widths at half-maximum.
This is a characteristic of the electron LINAC at the operating currents used. 
The irradiated foils were assayed by the ISU Environmental Radiation Measurements Laboratory 
using standard high-purity germanium (HPGe) gamma spectrometry systems
(Canberra/GenieTM) calibrated against National Institute of Standards and Technologies (NIST)-
traceable standards.  The induced activities in the free-beam foils were estimated from the net 
79
photo peak areas and system  efficiencies per standard  procedures for the GenieTM system.  The 
measured  activities of
Figure 9.  Electron energy spectra for the three accelerator energies examined.
the heavy indium foils in the boron sphere were corrected for gamma self-shielding using an 
escape fraction at 336 keV, calculated using a combination of MCNP9 numerical computations
and handbook data for the specific source-detector geometry that was used for the assay.  The 
escape fraction used for these foils was 0.85 ± 0.02.  The other foils had much higher escape 
fractions, greater than 0.95.  Finally, the measured induced activities of the foils were then 
converted to equivalent saturation activities using the standard radioactive isotope buildup and 
decay formulas.
RESULTS
The measured saturation activities of the various foils are shown in Tables 2-4.  Some entries in 
these tables are listed as “Not Available” for various reasons.  In the case of the 336 keV line 
from inelastic scatter in indium, the activity was so low that sometimes reliable results could not 
be measured, especially in the case of the lowest electron beam energy.  In a few other cases, the 
calibration of the spectrometer was suspect.   In any event, enough usable data was obtained for 
each case to produce a reasonable result for the neutron spectrum at the irradiation point.  The 
statistical uncertainties given in Tables 2-4 include the uncertainty of the spectrometer
calibration, as well as the uncertainty of the activity measurement for each foil. 
In each case, the measured activation results were used to derive the neutron spectra of the 
photoneutron flux at the measurement location using a direct, few-group, overdetermined, least-
squares matrix unfolding procedure, adapted by the INEEL for this type of measurement as 
discussed in Reference 8.  All theoretical system performance computations and effective foil 
activation cross section computations that were required to support the unfolding process 
described in the reference were performed using the MCNP9 and ITS10 codes.  Figures 10-12 
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show the unfolded, few-group, free-field neutron spectra at the downstream face of the bismuth
shield for each case. 
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Table 2.  Foil saturation activities measured at an electron energy of 4.6 MeV and an electron 
current of 94 microamperes.
Neutron Interaction Saturation Activity4 – First Foil 
(Bq/atom)
Saturation Activity- Second 
Foil (Bq/atom)
197Au (n, Ȗ)1 3.40 x 10-17  ( 5.5%) Not Available 
                          1293 keV 
115In (n, Ȗ)2     1097 keV 
                            416 keV 
2.37 x 10-17  ( 5.1%) 
2.52 x 10-17  ( 5.1%) 
2.37 x 10-17  ( 5.1%) 
2.18 x 10-17  ( 5.1%) 
2.26 x 10-17  ( 5.1%) 
2.30 x 10-17  ( 5.1%) 
197Au (n, Ȗ)2 3.04 x 10-17  ( 5.5%) 3.04 x 10-17  ( 5.8%) 
63Cu (n, Ȗ)2 9.80 x 10-20  ( 5.7%) 1.19 x 10-19  ( 5.9%) 
115In (n,n')3 Not Available 5.94 x 10-22  (42.7%) 
1. Bare foil.
2. Cadmium covered foil. 
3. Foil in boron sphere. 
4. Percentage uncertainty (1ı) given in parentheses.
Table 3.  Foil saturation activities measured at an electron energy of 8.0 MeV and an electron 
current of 64.6 microamperes.
Neutron Interaction Saturation Activity4 – First Foil 
(Bq/atom)
Saturation Activity- Second 
Foil  (Bq/atom)
197Au (n, Ȗ)1 Not Available 7.37 x 10-17  ( 5.1%) 
                         1293 keV 
115In (n, Ȗ)2       1097 keV 
                           416 keV 
4.70 x 10-17  ( 5.0%) 
4.87 x 10-17  ( 5.0%) 
4.74 x 10-17  ( 5.0%) 
4.46 x 10-17  ( 5.0%) 
4.61 x 10-17  ( 5.0%) 
4.64 x 10-17  ( 5.0%) 
197Au (n, Ȗ)2 6.86 x 10-17  ( 5.1%) 6.60 x 10-17  ( 5.1%) 
63Cu (n, Ȗ)2 2.36 x 10-19  ( 5.2%) 2.47 x 10-19  ( 5.3%) 
115In (n,n')3 6.24 x 10-22  ( 7.1%) 5.17 x 10-22  (8.4%) 
1. Bare foil.
2. Cadmium covered foil. 
3. Foil in boron sphere. 
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4.   Percentage uncertainty (1ı) given in parentheses. 
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Table 4.  Foil saturation activities measured at an electron energy of 11.7 MeV and an electron 
current of 112.6 microamperes.
Neutron Interaction Saturation Activity4 – First Foil 
(Bq/atom)
Saturation Activity- Second 
Foil (Bq/atom)
197Au (n, Ȗ)1 Not Available 1.17 x 10-16  ( 5.3%) 
                         1293 keV 
115In (n, Ȗ)2     1097 keV 
                          416 keV 
Not Available 
Not Available 
Not Available 
Not Available 
Not Available 
Not Available 
197Au (n, Ȗ)2 1.08 x 10-16  ( 5.2%) 1.01 x 10-17  ( 5.4%) 
63Cu (n, Ȗ)2 3.70 x 10-19  ( 5.5%) 3.96 x 10-19  ( 5.9%) 
115In (n,n')3 4.60 x 10-21  (5.5%) 4.35 x 10-21  (7.7%) 
1.   Bare foil.
2. Cadmium covered foil.
3. Foil in boron sphere.
4.   Percentage uncertainty (1ı) given in parentheses. 
The unfolding method produces the imputed unperturbed spectrum at the location of the center 
of the boron sphere, corrected for self-shielding and corrected for the effect of the radial flux 
distribution across the foil holding plate, because not all of the foils were actually located at the 
center.  The computed a-priori neutron spectra, normalized to produce the same total integrated 
flux corresponding to the measurement, are also shown in Figures 10-12 for comparison.  The 
unfolding group structures used to represent the measured spectra were selected to provide well-
conditioned unfolding matrices, and to permit the most accurate integration of the measured
spectra in the epithermal energy range to determine the total epithermal neutron flux.
It will be observed that the propagated uncertainties associated with the thermal fluxes (E < 
0.404 eV) in Figures 10-12 are quite large.  This is because, by design, the thermal flux is very 
small compared to the remainder of the spectrum in each case.  The measured activities of the 
gold foils with and without Cd covers differ by only a few percent --- a difference that is 
comparable to the uncertainties of the activities themselves.  This leads to a magnification of the 
uncertainty when the thermal flux is estimated from these foil activities in the spectral unfolding
process.  The propagated uncertainty associated with the high-energy neutron flux in the case of 
the lowest electron beam energy, is also quite large.  This is because the high-energy flux is so 
low in this case.
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Figure 10.  Unfolded neutron flux spectrum obtained by direct fitting of least-squares fitting of 
foil activation data for Ee = 4.7 MeV and Je  = 94 microamperes.
Figure 11.  Unfolded neutron flux spectrum obtained by direct least-squares fitting of foil 
activation data for Ee = 7.97 MeV and Je = 64.6 microamperes.
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Figure 12.  Unfolded neutron flux spectrum obtained by direct least-squares fitting of foil 
activation data for Ee = 11.7 MeV and Je = 112.6 microamperes.
Table 5 shows some integrated parameters computed from the unfolded spectrum data.  In 
particular, the integrated fast (E > 10 keV) and epithermal (0.414 < E < 10 keV) fluxes, 
normalized to a current of 1 milliampere in each case, are given.  As anticipated, there is an 
optimum near 8 MeV electron beam energy. Lower electron beam energies produce lower 
epithermal fluxes because of the lower overall neutron yield.  Higher electron beam energies 
produce a higher yield, but there is a larger fast-neutron component in the source, at the expense 
of the epithermal component if the filter/moderator thickness is held constant. 
Table 5.  Integral flux parameters for the measured photoneutron spectra. 
Electron
Energy
(MeV)
Electron
Current
(mA)
Fast Neutron 
Flux (n/cm2-s-mA)
Epithermal Neutron 
Flux (n/cm2-s-mA)
4.6 0.094 4.27 x 105 ( 33%) 4.54 x 106  (11%) 
8.0 0.065 1.81 x 106 (12%) 1.53 x 107  ( 6%) 
11.7 0.113 2.94 x 106 ( 9%) 1.34 x 107    (9%) 
Note:  Percentage uncertainty (1ı) given in parentheses. 
86
Additional neutron moderating and filtering material would reduce this fast neutron component,
but the additional filtering thickness would increase the geometric divergence of the neutron 
source.  Multiplying the measured epithermal neutron flux for the medium energy case by the 
design current for a full-scale device (100 mA) yields a useful  epithermal flux of 1.5 x 109
n/cm2-s.  This flux level is comparable to that of typical research reactor-based epithermal
neutron sources used for recent clinical trials of BNCT5-7.
A simple, but widely used, metric for the quality of epithermal-neutron beams is based on 
dividing the free-field neutron KERMA rate of the beam (integrated over all energies above 
thermal) by the useful epithermal-neutron flux, again measured in the free field.  This parameter
is an indicator of the non-selective background dose that will be produced in tissue by the above-
thermal spectral component of the beam itself, in the absence of any neutron capture agent that 
may be administered to the patient. It can be computed using the measured flux spectrum in 
conjunction with broad group KERMA factors based on standard data for the components of 
biological tissue11.  This procedure yields the results shown in Table 6 for all three electron beam
energies.  In this table, the neutron KERMA rate is first normalized to the electron current.  For 
the medium electron energy case, the measured free-beam neutron contamination is 5.7 x 10-11
cGy total neutron KERMA from all components per unit useful epithermal-neutron fluence 
(estimated uncertainty approximately 10%).  This is within the range that has historically been 
considered clinically acceptable, although a few more centimeters of filtering to bring this 
component of the beam down to the range of about 2.0 x 10-11 cGy per unit flux would be 
desirable in a clinical device.  Approximately 91% of the background neutron dose results from
proton recoil. The remainder is from other recoil components.  Additional background dose in 
tissue is, of course, produced by non-selective thermal-neutron induced components, primarily
from neutron capture in nitrogen and hydrogen, but these components are not directly indicative 
of the intrinsic biophysical quality of the incident beam.  They must be taken into account in 
treatment planning, but they are not normally included in the free-beam quality parameter
discussed here. 
Table 6.  Neutron KERMA parameters for the measured photoneutron spectra. 
Electron
Energy
(MeV)
Electron
Current
(mA)
Neutron KERMA 
Rate (mrad/mC)
Neutron
Contamination
(cGy-cm2)
4.6 0.094 0.15 3.32 x 10-11
8.0 0.065 0.88 5.72 x 10-11
11.7 0.113 1.86 1.39 x 10-10
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Finally, the photon contamination of the neutron source can be estimated by dividing the 
measured photon dose rate (from the ion chamber shown in Figure 7) by the measured electron 
current.  For the measurements presented here, this procedure yields the results shown in Table 7 
for all three electron beam energies.  The dose rates are approximately three orders of magnitude
smaller than was measured in the earlier experiments, where the electron beam axis passed 
through the neutron flux measurement location (Figure 3).  Thus, the objective of significantly 
reducing the photon contamination of the neutron beam using an arrangement with the neutron 
beam axis at right angles with the electron beam axis was achieved by a combination of 
geometry and shielding at the measurement location. 
Table 7.  Photon dose and KERMA parameters for the measured photoneutron spectra. 
Electron
Energy
(MeV)
Electron
Current
(mA)
Photon Dose 
Rate (mrad/mC)
Photon
Contamination
(cGy-cm2)
4.6 0.094 12.2 2.69 x 10-9
8.0 0.065 13.2 8.54 x 10-10
11.7 0.113 14.1 1.05 x 10-9
Dividing the photon dose rates in Table 7 by the useful epithermal neutron flux provides 
estimates of the free-beam photon contamination in each case.  In the case of the 8 MeV electron 
beam, this produces a value of 8.5 x 10-10 gamma dose per unit useful epithermal neutron 
fluence.  This is approximately 40 times higher than is clinically desirable, but Monte Carlo 
computations using the MCNP code show that the incident photon dose rate at the irradiation 
point can be reduced as needed by the appropriate placement of additional shielding around the 
electron accelerator target, as shown in Figure 2.  Such shielding was not installed in the 
apparatus discussed here because of difficulties associated with the constraints imposed by a 
fixed electron drift tube length, in combination with the fixed configuration of the concrete 
shielding between the accelerator and the neutron production assembly.  Finally, it can be seen 
that there is a minimum in the photon contamination at an electron beam energy in the range of 8 
MeV, as expected.  This is because higher electron beam energies produce a higher gamma dose 
rate without a commensurate increase in the epithermal neutron flux, as discussed previously. 
DISCUSSION
The results presented here provide experimental validation of the expected performance of the 
electron accelerator-based concept for production of medically useful epithermal-neutron
sources for neutron capture research research. The efficiency (in terms of useful neutrons 
produced per initial accelerated charged particle) of the electron accelerator-based approach 
presented here is somewhat smaller than is typical for various light-ion  accelerator-based 
schemes (see, for example, Reference  12). However, the complicated target cooling schemes
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associated with such systems are not required for the electron-based system.  Furthermore, the 
accelerator target (or multiple targets) can be integrated into the central D2O containment
structure in such a manner that the heavy water also serves as a target coolant, with circulation of 
the D2O through a heat exchanger via a closed system to contain the tritium that is produced by 
neutron capture in deuterium.
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